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1. Introduction 
1.1 Skeleton general  
The skeleton of vertebrates is composed of approximately 200 elements. All these 
elements have their own shape, size and location. The skeleton is a complex organ 
made of two distinct tissues, cartilage and bone. Its main functions are to provide 
mechanical support (ribs), to allow locomotion (long bones), to provide protection 
(scull bones, ribs) and to act as a metabolic reservoir (Karsenty, 2003; Stevens and 
Lowe, 2005, Karsenty and Wagner, 2002). The skeleton is divided into three parts: 
the craniofacial skeleton, the axial skeleton (vertebrae, pelvis and ribs) and the 
appendicular (limb) skeleton (bones of forelimbs and hindlimbs). These structures 
are formed by cells of different origin: the craniofacial skeleton is formed by cranial 
neural crest cells, the axial skeleton is derived from somites (paraxial mesoderm) 
and the limbs are products of the lateral plate mesoderm (Olsen, et al., 2000). 
 
 
Figure 1: The anatomy of the forelimb. 
E18.5 mouse embryo. From proximal to distal (from left to right, respectively): scapula, humerus, ulna 
and radius (lower and upper bones, respectively), carpal, metacarpal bones and phalangeal bones. 
 
To decipher the mechanism of bone development two model systems are used 
widely- chick and mouse embryos. A number of the experiments are done on the 
long bones of the skeleton, particularly on the fore- and/or hindlimbs. The forelimb 
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consists of scapula, humerus, ulna and radius, carpal, metacarpal and phalangeal 
bones (Fig.1, direction from proximal to distal) (Kaufmann, 1992).  
Histologically skeleton is made out of two tissues: cartilage and bone. Cartilage is 
avascular and consists of chondrocytes. Cartliage matrix is reach of collagen type II 
and can be mineralized, but to a lesser extent than the bone matrix (Cormack, 1987). 
Cartilage can grow both by internal expansion and by apposition. Bone is a highly 
vascular tissue which is heavily mineralized. Two types of cells are present in the 
bone: osteoblasts and osteoclasts. Osteoblasts produce a bone matrix whereas 
osteoclasts resorb this matrix. The osteoblasts, embedded in the bone matrix are 
called osteocytes. The bone matrix is reach in collagen type I and hydroxiappatite 
crystalls (Ca10(PO4)6(OH)2). Bone can grow only by apposition, i.e. by laying down of 
additional matrix and cells on the free surface of existing bone (Cormack, 1987; 
Alberts et al., 2002). Interestingly, condrocytes and osteoblasts are of mesenchymal 
origin, whereas osteoclasts derive from the myelomonocytic lineage (Cormack, 
1987; Erlebacher et al., 1995; Ducy et al., 1997).  
Bone is a dynamic system, which is build and resorbed, i.e., remodeled throughout 
the embryonic development and adult life. 
 
1.2 Bone formation  
Bones develop by two mechanisms: by intramembranous ossification directly in 
vascularized mesenchyme and by endochondral ossification in the center of 
cartilaginous models (cartilage anlage) of future bones (Kormack, 1987).  
1.2.1 Intramembranous ossification 
The cranial and facial flat bones, mandible and clavicles develop directly from 
mesenchymal cells by a process called intramembranous ossification (Kormack, 
1987; Stevens and Lowe, 2005). Mesenchymal cells proliferate and condense, 
forming compact nodules. Some of these cells change their shape and become 
osteoblasts. The osteoblasts secrete bone matrix, which is able to bind calcium. 
Further, bony spicules radiate out from the region where ossification began. Later, 
the whole region of bone spicules becomes surrounded by the periosteum- a 
membrane of compact mesenchymal cells which surrounds the bone (Gilbert, 2003). 
The cells on the inner surface of the periosteum become osteoblasts, which deposit 
bone matrix parallel to existing spicules providing the growth of the bone. It was 
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established that during intramembranous bone formation the osteoblasts are 
differentiating through four distinct stages: early preosteoblast, preosteoblast, 
chondrocyte-like osteoblast and mature osteoblast stages (Abzhanov et al., 2007). 
1.2.2 Endochondral ossification 
The bones of the axial and appendicular skeleton are also derivatives of 
mesenchyme, but they develop indirectly through a cartilage model. Such bones 
develop and grow as a result of progressive replacement of preexisting cartilage. 
This complex process is called endochondral ossification (Fig.2). Briefly, clusters of 
mesenchymal cells adhere and form condensations. The cells in the condensations 
differentiate into chondrocytes, the primary cell type of cartilage. The cells at the 
border of condensations form the perichondrium, a sheeth of fibroblast like cells. 
Chondrocytes in the center of the cartilage model proliferate and synthesize type II 
collagen, one of the major components of the cartilage matrix. As the cartilage 
anlagen enlarge in size, the chondrocytes in the center stop proliferating and 
undergo hypertrophy. These cells change their genetic program and synthesize type 
X collagen (Col10a1). The hypertrophyc chondrocytes mineralize the surrounding 
matrix and trigger the invasion of blood vessels. The hypertophic chondrocytes 
undergo cell death. Perichondrial cells adjacent to the hypertrophic chondrocytes 
differentiate into osteoblasts, which form the so called bone collar. Some of the 
osteoblasts of the periosteum invade the hypertrophic region of the cartilage 
template along with blood vessels and start the production of bone matrix using the 
degraded cartilage matrix as a scaffold (de Crombrugghe et al., 2001; Kronenberg, 
2007). The blood vessels also bring osteoclasts, which degrade the extracellular 
matrix produced by hypertrophyc chondrocytes. Postnatally, as bones grow further, 
the secondary-ossification centers are formed (Fig.2). That occurs when the 
chondrocytes in epiphyseal cartilage of the long bones stop proliferating, 
hypertrophy, and attract blood vessels to invade along with osteoblasts and 
osteoclasts (Kronenberg, 2003). The cartilage between the primary spongiosa and 
secondary ossification center is called “growth plate”, as it enables the long bone to 
grow postnatally (Kronenberg, 2003; Gilbert, 2003). Addition of the new bone to the 
outer surface of long bones is continuously maintained in adult life by 
intramembranous ossification from the periosteum (Erlebacher et al., 1995; Stevens 
and Lowe, 2005). 
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Figure 2: Endochondral ossification 
Mesenchymal cells condence, aggregate and differentiate in to chondrocytes to form cartilage anlage 
of bone (A, B). Chondrocytes proliferate and cells in the center of cartilage model undergo 
hypertrophy (C). Hypertrophyc chondrocytes change and mineralize their extracellular matrix and 
undergo cell death, allowing blood vessels to enter (D). Blood vessels bring in osteoclasts, which 
degrade cartilaginous matrix, and osteoblasts, which deposit bone matrix on the remnants of 
degraded matrix (E, F). The secondary ossification centers are formed as chondrocytes in new 
locations stop proliferating undergo hypertrophy and attract blood vessels along with osteoblasts (G). 
A plate of the cartilaginous cells between the bone of primary spongiosa and secondary ossification 
center called growth plate (H) (From Gilbert, 2003). 
 
1.2.3 Organization of cartilage 
Based on the cellular organization, matrix composition and gene expression profile 
the cartilage can be subdivided into several zones: periarticular, proliferating, 
prehypertrophyc, hypertrophyc and terminal hypertrophyc chondrocytes (Fig.3). The 
periarticular chondrocytes consist of small round cells located close to the 
epiphyseal end of skeletal element. Proliferating chondrocytes secrete matrix rich in 
collagen type II. They can be divided morphologically into two types of cells: small 
round cells, which are located closer to the distal end of the epiphysis and flattened 
cells which are organized in columns. Prehypertrophic chondrocytes are cells larger 
in size which synthesize Indian hedgehog (Ihh) (Fig.3, C) (Vortkamp, et al., 1996). 
The postmitotic hypertrophic chondrocytes sectere a mineralized matrix rich in 
collagen type X (Olsen, et al., 2000; Kronenberg, 2007). The terminal hypertrophyc 
chondrocytes complete the differentiation process, undergo cell death and are 
replaced by bone. These chondrocytes express matrix metalloproteinase 13 
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(MMP13) and osteopontin (Spp1). The mineralized bone collar or periosteum, which 
consists of osteoblasts is flanking the hypertrophic cells approximately where the 
transition between proliferating and hypertrophyc chondrocytes takes place (Fig.3, B; 
Olsen, 2000). 
 
 
Figure 3: Cellular organization of developing cartilage 
The cartilage is divided into zones of periarticular, proliferating, prehypertrophyc, hypertrophyc and 
terminal hypertrophyc chondrozytes (A). A section of an E 16.5 mouse radius was stained by von 
Kossa staining and counterstained with Nuclear Fast Red to visualize mineralized matrix (B). A 
parallel section was hybridized with an antisense riboprobe for Ihh (white) to demarcate the zone of 
prehypertrophyc chondrocytes. The tissue was counerstained with Toluidin blue (C). pc- 
perichondrium, po- periosteum 
 
1.3 Relevant mechanisms 
1.3.1 Hedgehog signaling  
Indian hedgehog is a signaling molecule (secreted factor) that is expressed in the 
prehypertrophic chondrocytes (Bitgood and McMahon, 1995). No endochondral bone 
is formed in Ihh-deficient mice indicating that Indian hedgehog is essential for 
endochondral ossification (St-Jacques et al., 1999).  
It was shown that Ihh directly stimulates chondrocyte proliferation and indirectly 
supresses chondrocyte hypertrophy. Ihh activates PTHrP in the periarticular cells, 
which in turn acts through its receptor, PPR (PTH/PTHrP receptor), to prevent 
hypertrophyc differentiation of the chondrocytes (Vortkamp et al., 1996; Lanske et. 
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al., 1996; Weir et al., 1996; Karp et al., 2000). Thus, the two signals interact in a 
negative-feedback loop, in which the level of Ihh determines the distance between 
the periarticular region and the chondrocytes undergoing hypertrophy (Vortkamp et 
al., 1996). The regulation of chondrocyte proliferation is controlled directly by Ihh 
signalling, which is most likely mediated through Cyclin D1 (Long et al., 2001, Lai 
and Mitchell, 2005).  
Ihh is also required to direct perichondrial cells to differentiate into osteoblasts which 
form the periosteum (St-Jacques et al., 1999; Long et al., 2004; Kronenberg, 2007). 
It was established later, that Ihh signaling is required at the earliest stage of 
osteoblast development but has no pronounced effect on the subsequent 
differentiation of osteoblasts (Hu et al., 2005; Rodda and McMahon, 2006). Thus, Ihh 
acts as a key coordinator of chondrogenesis and osteogenesis in endochondral 
bones (Chung, et.al., 2001; Kronenberg, 2007). ).  
1.3.2 Transcription factors Runx2 and Osx regulate bone formation 
Runx2, previously also called Cbfa1, is a member of runt family of transcription 
factors. During mouse embryonic development it was first detected at E 10.5 in 
lateral plate mesoderm and in all cells of the mesenchymal condensations 
prefiguring the future skeletal elements. Between E 10.5 and E 12.5 Runx2 is 
continuously expressed in the osteochondro progenitor cells of the skeletal 
condensation (Ducy, et al., 1997). After E 12.5, Runx2 expression is steadily 
decreasing in prehypertrophic and hypertrophic chondrocytes until it becomes 
undetectable in these cells at birth. At the same time Runx2 expression increases in 
osteoblast progenitors and later becomes limited to the osteoblast lineage (Inada, et 
al., 1999; Kim, et al., 1999; Takeda, et al., 2001; Stricker, et al., 2002). Runx2 is also 
expressed in differentiated osteoblasts postnatally (Ducy, et al., 1999). Runx2 
activates osteocalcin expression by binding to the OSE2 site of osteoclacin 
promoter. Putative Runx2 binding sites were also found in the promoter of type I 
collagene, bone sialoprotein and osteopontin gene (Ducy, 2000). 
Runx2 deficient mice had a cartilaginous skeleton with complete absence of 
osteoblasts. (Ducy, et al., 1997; Komori et al., 1997; Otto et al., 1997; Harada and 
Rodan, 2003). Runx2-heterozygous mice had a defect in intramembranous 
ossification, which resembles cleidocranial displasia in humans, a desease caused 
by mutation in Runx2 (Mundlos, et al., 1997; Otto, et al., 1997; Zelzer and Olsen, 
2003). Analysis of Runx2-null mice on the molecular level revealed that Runx2 is 
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required for osteoblast differentiation and positively regulates hypertrophic 
chondrocyte differentiation (Otto, et al., 1997; Komori, et al., 1997; Stricker, et al., 
2002). Ectopic expression of Runx2 leads to endochondral ossification in parts of the 
skeleton that normally never ossify demonstrating that Runx2 is sufficient to induce 
osteoblast differentiation (Takeda et al., 2001; Ueta et al., 2001). Overexpression of 
Runx2 under the collagen I promoter in mice leads to osteopenia, demonstrating that 
Runx2 promotes early differentiation steps and inhibits the later stage of osteoblast 
maturation (Liu et al., 2001). Transgenic mice expressing a dominant-negative form 
of Runx2 under the osteocalcin promoter (e. g. in mature osteoblasts), showed 
decreased bone formation and reduced bone mass. This demonstrates that once 
osteoblasts differentiation is initiated Runx2 continues to regulate their function, and 
therefore bone formation, postnatally (Ducy et al., 1999).  
Osterix (Osx) is a novel zinc finger-containing transcription factor which is expressed 
in differentiating chondrocytes and surrounding perichondrium of E 13.5 mouse 
embryos. At E 15.5 and later Osx is expressed in the osteoblasts and weakly 
expressed in prehypertrophic chondrocytes. This transcription factor is essential for 
osteoblast differentiation, acting downstream of Runx2 (Nakashima, et al., 2002).  
1.3.3 Mechanism of mineralization  
1.3.3.1 Matrix vesicles 
Hypertrophic chondrocytes and osteoblasts initiate the mineralization in vivo by 
releasing matrix vesicles in the extracellular matrix. Matrix vesicles (MVs) are 
membrane particles about 50-200 nm in diameter. Studies performed by scanning 
and transmission electron microscopy indicated that MVs are released from the cell 
surface via polarized budding into the extracellular space (Fig. 4) (Anderson et al., 
2005; Xiao et al, 2007). They serve as the initial sites of calcification, since they 
accumulate Ca2+ ions and inorganic phosphate (Pi) which finally leads to 
hydroxyapatite [3Ca3(PO4)2.(OH)2]) formation (Anderson, 1995; Anderson et al., 
2005; Balcerzak et al, 2008).  
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Figure 4: Scanning electron microscopy observation of matrix vesicles on 
osteoblast cell surface. 
Scanning electron microscopy observation of matrix vesicles on osteoblast cell surface (A-D). MVs 
are either scattered among collagen fibers (A, B) or aggregated on cell surface (C, D). Higher 
magnification of MVs are shown in (B) and (D), respectively. Transmission electron microscopy 
observation of the budding MVs in the osteoblast cell culture (a-d). The vesicles first aggregate under, 
then pinch off from plasma membrane in a sac (b, c, d are higher magnifications of the marked 
regions from (a). Adopted from Xiao et al., 2007 
Deposition of mineral occurs in two phases. During phase 1 the first crystals of 
hydroxyapatite are formed within MVs. Later, as the crystals become bigger, they 
penetrate the membrane of MVs, exposing pre-formed mineral to the extracellular 
fluid (phase 2- mineral propagation, or maturation) (Garimella et al., 2004; Anderson, 
1995; Garimella et al., 2006). 
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MVs are rich of various enzymes, which enable the process of mineralization. Thus, 
the outer surface of MVs includes enzymes involved in the hydrolysis of organic 
phosphate esters. These are tissue nonspecific alkaline phosphatase (TNAP), 
nucleotide triphosphate pyrophosphatase phosphodiesterase (NPP1), ATPase and 
5’-AMPase. NPP1 generates pyrophosphate (PPi) from nucleoside triphosphates 
(Fig. 5). Alkaline phosphatase is one of the most abundant enzymes of MVs. It 
enables hydrolysis of AMP or pyrophosphate (PPi) to yield phosphate residue (Pi) 
(Fig. 5). It was shown that a deficiency of the TNAP gene causes the disease 
hypophosphatasia, which is characterized by weakly mineralized bones. Alkaline 
phosphatase-deficient mouse model confirmed the previous hypothesis that TNAP 
stimulates mineralization, since these mice shown skeletal hypomineralization 
(Anderson at al., 2004) (Fig. 5). 
The rate of mineralization is tightly regulated by the activity of these enzymes and 
the product of their activity. Several research groups confirmed that for example PPi 
can also regulate the mineralization process in a concentration-dependent manner. 
Thus, low concentration of PPi (< or = 0.01 mM) promote mineralization, whereas 
concentrations higher than 1-2 mM inhibit mineralization (Harmey et al., 2004; 
Garimella et al., 2006).  
 
 
Figure 5: Metabolism of ATP by NPP1 and TNAP. 
ATP is hydrolyzed by NPP1 to yield AMP and pyrophosphate (PPi). Both AMP and PPi are further 
hydrolyzed to orthophosphate (PO43-) by TNAP. The orthophosphate molecules are then incorporated 
into CaPO4 molecules. High concentrations of PPi block the formation of CaPO4. Adopted from 
Anderson at al., 2004 
 
Matrix metalloproteases (MMPs) such as MMP-2, MMP-9 and MMP13 were also 
found to be present in the outer surface of matrix vesicles membranes (Balcerzak et 
al, 2008). MMPs are the proteases, which cleave the protein components of the 
ECM, and, therefore, are important in tissue remodeling (Stamenkovic, 2003). The 
inner surface of MVs is rich in Annexins and phosphatidylserine (PS). PS is found in 
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complexes with Ca2+ and Pi ions (Sauer and Wuthier, 1988; Wu et al., 1993; Genge 
et al., 2008). Annexin V was shown to promote the inward transport of Ca2+ and to 
enhance the nucleation of the amorphous calcium phosphate in complex with 
phosphatidylserine (Genge et al., 2007). The binding of Annexin V to type II and type 
X collagens stimulates its Ca2+ channel activity (Huitema and Vaandrager, 2007).  
A novel phosphatase, PHOSPHO1 has been localized in the inner surface of MVs 
and suggested to act synergistically with TNAP in generating Pi (Stewart et al., 2006; 
Roberts et al., 2007). 
1.3.3.2 Extracellular bone matrix proteins regulating mineralization 
Bone sialoprotein (Bsp or Ibsp), osteopontin (Osp or Spp1), osteonectin (On) and 
osteocalcin (Osc) are non-collagenous bone matrix proteins, which are capable to 
bind Ca2+ ions. It has been shown that Bsp has a high affinity to Ca2+ ions and 
hydroxyapatite and that Bsp is promoting nucleation of hydrohyappatite crystals, 
thus, promoting mineralization of the bone (Hunter and Goldberg, 1993; Ganss et al., 
1999). In contrast, osteopontin, which shares many of the properties of Bsp, is 
inhibiting mineralization (Ganss et al., 1999). Osteonectin and Osteocalcin (Osc) 
have been shown to inhibit mineralization in vivo. Osc-deficient mice show an 
accelerated rate of bone formation without impairing bone resorption (Ducy et al., 
1996; Boskey et al., 1998; Boskey et al., 2003)  
Collagens play an important role in nucleating and orienting newly formed apatite 
crystals during mineralization. Thus collagen of types I and II can promote mineral 
propagation (Anderson et al., 2005). It has been also shown that type I collagen is 
essential for retaining BSP at high concentrations, thus enhancing Bsp-mediated 
matrix mineralization (Xu et al., 2007). 
 
1.4 Tmem16 gene family 
The Tmem16 gene family was discovered by two independent groups. In silico 
analysis of human sequences (chromosome) made by Katoh et al., identified a novel 
gene family designated Tmem16. It consists of at least eight members in humans 
(Tmem16A, Tmem16B, Tmem16C, Tmem16D, Tmem16E, Tmem16F, TP53I5 
(PIG5), and PCANAP5 (NGEP) (Katoh et al., 2004 (a); Katoh, 2004 (b). These 
genes encode proteins with homologous eight-transmembrane domains (TM) and a 
conserved domain referred to as DUF590 (Domain of Unknown Function 590, PFAM 
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Accession No.: PB175613). Three domains (TM16H1-TM16H3) were identified, as 
being highly conserved among the TMEM16 family proteins. It was suggested, that 
the N- and C-terminus of these proteins are facing the cytoplasm. Interestingly, the 
DUF590 domain was found to be highly conserved among different species, 
including human, mouse, rats and flies. Phylogenetic analysis revealed TMEM16E 
and TMEM16F constitute a subfamily among TMEM 16 family proteins (Katoh, 2004 
(a). 
Another research group has mapped and identified the gene linked to the human 
disease Gnathodiaphyseal Dysplasia GDD1 (Tsutsumi et al., 2003; Kamata, 2004). 
Gnathodiaphyseal dysplasia is a syndrome inherited in autosomal dominant fashion. 
This rare syndrome exhibit increased bone fragility, sclerosis/bowing of tubular 
bones and fibro-osseous lesions of the jawbones (Riminucci et al., 2001). It was 
found, that this disease is caused by the missense mutations (C356R and C356G) of 
GDD1 (Tsutsumi, 2004). It was established later that GDD1 and TMEM16E 
represent the same gene which is also found in mouse and other mammals.
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1.5 Aim of the study 
It has been demonstrated that Ihh, the signaling factor which is expressed by 
prechypertrophic chondrocytes, is crucially important for endochondral bone 
development. Ihh signaling regulates chondrocyte proliferation and differentiation 
and plays a key role in osteoblasts formation (Vortkamp et al., 1996; Lanske et. al., 
1996; Weir et al., 1996; Karp et al., 2000; St-Jacques et al., 1999). It was recently 
shown that Ihh directs perichondrial cells to differentiate into osteoblasts (Long et al., 
2004; Kronenberg, 2007). Ihh determines the site of bone collar formation in the 
adjacent perichondrium and acts as a key coordinator of chondrogenesis and 
osteogenesis in endochondral bone (Chung et al., 2001; Kronenberg, 2007). In a 
previous scan for Ihh target genes several genes were identified (Wenzel, 2003). 
One of them, Tmem16f, was found to be expressed in a newly formed bone and in 
the periosteum surrounding Ihh domain in E14.5 and E16.5 mice. Additionally, it was 
shown that Tmem16f expression is upregulated by activation of Ihh signalling 
(Wenzel, 2003). Thus, we suggested that Tmem16f might be involved in a regulation 
of bone formation downstream of Ihh.  
The aim of the present study was to analyze the function of Tmem16f. First, since 
only a part of Tmem16f sequence was isolated by the previous study, an assembly 
of its complete sequence along with the determination of exon-intron structure, start-
codon and open reading frame was required. 5’-RACE was carried out to determine 
the complete 5’-end sequence of Tmem16f. Second, in silico methods were essential 
to predict isoforms of Tmem16f, protein sequence and its structure, transmembrane 
domains, functional domains and sites of glycosilation. Third, the determination of 
Tmem16f cell localization could potentially indicate its possible function in the cell. 
Fourth, to further study the function of Tmem16f it was necessary to develop a 
strategy to generate Tmem16f-null mice.  
Mice lacking Tmem16f were generated by complete deletion of Tmem16f. 
Additionally, Tmem16f gene trap mouse line which carries a truncated version of 
Tmem16f protein was generated. This approach allows comparison of the phenotype 
of two mouse lines which might unravel the function of potential Tmem16f domain(s). 
To analyze the phenotype on the molecular level in situ hybridization was performed 
using the chondrocyte- and osteoblast-specific markers. Mineralization of the bone 
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was analyzed by histological staining for Ca2+-ions. Additionally, analysis of alkaline 
phosphatase as one of the markers of osteoblast activity to mineralize the matrix and 
analysis of Tartrate Resistant Alkaline Phosphatase as a marker of osteoclasts 
which resorb the bone was performed to investigate the impaired ossification in 
mutant mice.  
The results of this study help to clarify the regulation of Tmem16f by Ihh, Runx2 and 
Osx. 
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2. Materials and methods 
2.1. Materials 
2.1.1 Chemicals 
Acetic anhydride (Sigma) 
Agar (Difco or Roth) 
Agarose (Gibco BRL) 
Ampicilin (Sigma) 
BSA (New England Biolabs, USA) 
Carbenicillin disodium salt (GERBU biotechnik GmbH) 
Chloroform (Roth) 
Coverslips for in situ hybridization (Roth) 
CTP, GTP, ATP, UTP (Roche) 
Dextran Sulfat (Sigma) 
DNAse (deoxyribonuclease), RNAse free (Roche) 
dNTPs (2'-Deoxynucleoside 5'-triphosphates) (Roche) 
DPX Mountant for histology (Fluka)- DPX Mountant for histology (Fluka) 
Eosin Sigma 
Ethanol (Roth) 
Ethidiumbromide (Serva or Roth) 
Fatfree milk (Instant-Magermilchpulver, Neuform, Germany) 
Ficoll 400 (Pharmacia) 
Forceps 5, 55 Dumont, Switzerland 
Glass coverslips (Menzel-Glaeser, Germany) 
Glutaraldehyde (Sigma) 
Glycerol (Merk) 
Glycogen (Roche) 
Hematoxylin Sigma 
Isopropanol Roth 
Kanamicin Sigma 
Nuclear fast red (Sigma) 
Orange G (Sigma) 
O.C.T. (Optimal Cutting Temperature), Tissue Tek  
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Paraffin-paraplasts (Sherwood Medical Co, USA) 
PFA (Paraformaldehyde) (Merck) 
Phenol (Roth) 
Proteinase K (Roche) 
[P32]-dCTP (3000 Ci/mmol) AmershamPharmacia, Freiburg 
[P33]-UTP (3000 Ci/mmol) AmershamPharmacia, Freiburg 
[P33]-UTP (2000 Ci/mmol), Hartmann Analytic, Braunschweig, Germany  
Restriction endonucleases (NEB, Roche) 
Ribonuclease A, RNAse A (Roche) 
RNAse inhibitor (Roche) 
Superfrost plus slides (Menzel-Glaeser, Germany) 
Taq-DNA polymerase (Eppendorf) 
TEA, triethanolamine (Merck) 
Toluidine Blue O (Sigma) 
TRIZOL Reagent (Invitrogen) 
Tryptone (Difco) 
T7, T3, SP6 RNA-polymerase (Roche) 
T4 DNA Ligase (Roche 1U/µl ) 
Yeast extract (Difco) 
Xylol (Roth) 
2.1.2 Kits, buffers and reagents  
 
Table 1: Kits. 
QIAprep plasmid mini prep kit Qiagen, Germany 
Gene Racer Super Script II RT Module Invitrogen 
Super Script III First-Strand Synthesis 
System for RT-PCR 
Invitrogen 
Rediprime II Random Prime Labelling 
System 
Amersham Biosciences 
TOPO TA Cloning Kit for Sequencing Invitrogen 
Lumin Kit Roth 
Alkaline phosphatase (AP), Leukocyte  Sigma 
TRAP (acid phosphatase, leukocyte) Sigma 
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Table 2: Buffers for genomic DNA preparation from mammalian tissue. 
solution A  25 mM EDTA, pH8.0 
75 mM NaCl 
solution B  10 mM EDTA, pH8.0 
10 mM Tris-HCl, pH 8.0 
1% SDS (w/v) 
400 µg/ml Proteinase K 
 
Table 3: Buffers for DNA agarose gel electrophoresis. 
50X TAE buffer 2M Tris/acetate 
50mM EDTA 
pH 7.5- 8.0 
used as 1X solution 
10X TBE buffer 0.89M Tris base 
0.89M Boric acid 
2mM EDTA 
 pH 8.0 
used as 1X solution 
10X loading buffer  
Ethidium bromide Roth, 
used at the concentration 0.5 µg/ml 
 
Table 4: Reagents and buffers for southern blot hybridization. 
Denaturation solution 1.5 M NaCl 
0.5 N NaOH 
Neutralization solution 1.5 M NaCl 
1M Tris (pH 7.4) 
20X SSC 300 mM Sodiumcitrate 
3 M NaCl; pH 7.0 
3MM Whatman filter paper VWR 
Nylon membrane Hybond 
micro spin columns  Amerscham 
Sodium –Phosphate (Na-P) 
 
1M Na2HPO4 
1M NaH2PO4 
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pH7.2 (reached using the same 
solutions) 
Church buffer (prehybridization) 7% SDS 
0,5 M Na-P, pH 7.2 
1 mM EDTA 
Church (hybridization) buffer Church buffer 
0.1 µg/ml fish sperm DNA 
500µg/ml Cot-DNA  
DNA from Hering sperm Serva electrophoresis 
Mouse Cot-1 DNA Invitrogen 
wash solution I 100 mM Na-P, pH 7.2 
0,1 % SDS 
wash solution II 50 mM Na-P, pH 7.2 
0,1 % SDS 
 
Table 5: Buffers for mice genotyping. 
Tail lysis buffer: 50 mM Tris-HCl, pH 8.0 
100 mM EDTA 
1% SDS 
100 mM NaCl 
DirectPCR
®
Lysis Reagent (Tail) Peqlab 
 
Table 6: Reagents and buffers for in situ hybridization. 
10x transcription buffer Roche 
Proteinase K: 
 
stock solution 10mg/ml 
resuspended in 50 mM Tris-HCl, pH 8,0; 
1 mM CaCl2, stored at -20°C; 
working solution is 20 µg/ml 
 
PBS ((Phosphat Buffered Saline) 1.5 mM KH2PO4 
140 mM NaCl 
3 mM KCl, pH 7.4 
PFA Paraformaldehyde 4% (w/v) in PBS 
Hybridization buffer: 50% Formamid 
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3 M NaCl 
20 mM Tris-HCl; pH 7.4 
5 mM EDTA 
10 mM NaH2PO4-H2O; pH 8.0 
10% Dextran Sulfat (w/v) 
1x Denhardt's 
0,5 mg/ml Yeast RNA (total) 
50x Denhardt's reagent: 50g Ficoll 
5g polyvinylpyrrolidone 
5g BSA 
H2O to 500 ml 
RNAse free water (DEPC water) 0,1% DEPC (Diethylpyrocarbonat) 
10xWash buffer: 4 M NaCl 
0.1M Tris-HCl,  
0,05 M EDTA; pH 7.5 
RNAse A stock solution 10mg/ml; 
100µl dissolved in 400ml 1X wash buffer 
 
20x SSC (standard saline citrate):  300 mM Sodiumcitrate 
3 M NaCl; pH 7.0 
Photoemulsion (autoradiography 
emulsion type NTB2) 
Kodak, USA 
Kodak-developer D-19 Kodak, USA 
Kodak-fixer Kodak, USA 
Kodak Scientific Imaging Film Kodak, USA 
DPX Mountant for histology Fluka 
 
Table 7: Reagents and buffers for X-gal staining. 
Potassium Ferricyanide (K3Fe(CN)6) Sigma 
Potassium Ferricyanide 
(K4Fe(CN)6x3H2O) 
Sigma 
NP-40 Roth 
X-Gal Roth 
stock solution 40mg/ml in DMSO 
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Fixing solution 1XPBS 
1% formaldehyde 
 0.2% glutaraldehyde 
 0.02% (v/v) Nonidet P40  
Staining solution 1X PBS  
2mM MgCl2 
5mM K3Fe(CN)6 
5mM K4Fe(CN)6 
1mg/ml X-gal 
 
Table 8: Reagents and buffers for skeletal preparation. 
Alcian Blue 8 GX Sigma 
Alizarin Red S Sigma 
Alcian Blue solution 15mg of Alcian Blue 8GX 
80ml of 95%Ethanol 
20ml of glacial acetic acid 
Alizarin Red solution 50mg Alizarin Red 
1L of 1% or 2% KOH in water 
 
 
 
Table 9: Reagents and media for the cell culture. 
DMEM (Dulbecco's Modified Eagle 
Media): high glucose, with L-glutamine 
GIBCO (Invitrogen) 
FBS (FCS) GIBCO (Invitrogen) 
Penicilin/Streptomicin, 100X solution 
(contains 10,000 U of Penicillin, 10,000 
µg of Streptomycin) 
GIBCO (Invitrogen) 
Trypsin, 10 X solution GIBCO (Invitrogen) 
COS-7 growth medium DMEM, high glucose 
5% FBS 
Pen/Strep (1/100 of stock solution) 
6- or12-well plates, pipetts Corning 
15mm glass coverslips Roth 
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Polyfect Transfection Reagent QIAGEN 
Vectashield mountig medium with Dapi Vector 
 
2.1.3 Bacterial strain 
 
DH5α™  
F- φ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 endA1 hsdR17(rk-, mk+) phoAsupE44 
thi-1 gyrA96 relA1 λ- 
 
TOP10 
F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacΧ74 recA1 araD139 ∆(araleu) 
7697 galU galK rpsL (StrR) endA1 nupG 
2.1.4 Plasmids and vectors 
 
pBluescript II KS (+) Stratagene 
pCR4-TOPO, Invitrogen 
pEGFP-N3, Clontech 
pWH9, kindly provided by Reinhard Fässler  
2.1.5. DNA-probes for in situ hybridization 
 
Table 10: Mouse DNA probes for in vitro transcription. 
Probe Vector Insert 
size 
Restriction 
endonuclease 
(for antisense) 
RNA-
polymerase (for 
antisense) 
Reference 
mIhh pBSK 1800 bp Xba I T7 Bitgood and 
McMahon, 
1995 
mCol10a1 pBSK+ 400 bp Cla I T3 Jacenko et 
al., 1993 
mOsx pBS II 
KS+ 
660 bp Not I T3 Nakashima 
et al., 2002 
MMP13 pCR-21 1000 Hind III T7 Yamagiwa 
et al., 1999 
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mBspI pCR ~900 bp Not I SP6 (Young et 
al., 1994) 
mOsc pBSK 500 bp Xba I T3 Desbois et 
al., 1994 
Tmem16f pBS II 
SK 
220bp Bam H I T7 Chinenkova 
and 
Vortkamp 
 
2.1.6 Mouse lines 
Wild type NMRI mice were derived from Harlan Winkelmann (Germany branch) 
Wild type C57Bl/6J mice were derived from Harlan Winkelmann (Netherlands 
branch) 
Ihh deficient mice, Col-IIGal4 and UAS-Ihh transgenic mice were kindly provided by 
Andrew P. McMahon (Long et al., 2001; St-Jacques et al., 1999). 
Runx2 deficient mice were kindly provided by Stephan Mundlos, MPI Berlin 
Fixed limbs of Osx deficient mice were kindly provided by Knakashima  
2.1.7 Gene trap ES cells 
Bay Genomics California, USA 
2.1.8 Bioinformatics resources 
NCBI Blast                     http://www.ncbi.nlm.nih.gov 
Ensemble genome browser       http://www.ensembl.org/index.html 
MGI, mouse genome informatics              http://www.informatics.jax.org 
TMHMM- Prediction of transmembrane helices in proteins     
      
 http://www.cbs.dtu.dk/services/TMHMM-2.0 
UniProt database          http://www.uniprot.org 
PSORT- Prediction of protein subcellular localization        http://www.psort.org 
2.2 Methods 
2.2.1 Total RNA purification 
RNA was isolated using Trizol reagent (Invitrogen). The extraction was performed 
according to the manufacturer protocol. Limbs of E 16.5 or E 18.5 NMRI mouse 
embryo were collected and homogenized in 1 ml of Trizol. To remove insoluble 
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material from the homogenate, the mixture was centrifuged for 10 min at 12000 x g 
at 4oC. To separate the RNA from the genomic DNA and proteins 0,2 ml of 
chloroform was added to the homogenate, the sample was shaken, incubated at RT 
for 2-3min and centrifuged  at 12000 x g for 15 min at 4 0C. This step separated the 
mixture into a lower, phenol-chloroform phase, an interphase and an upper aqueous 
phase. RNA remains in the aqueous phase, which was then precipitated by mixing 
with isopropyl alcohol (0,5ml) followed by the 10 min incubation at RT and 
centrifugation at 12000 x g for 10 min at 2 to 8 0C. RNA pellet was washed with 75% 
ethanol, mixed by vortexing and centrifuged at 7500 x g for 5 min at 4 0C. The pellet 
was air-dried for 5-10 min and solved in 30µl to 50 µl RNAse free H20 (DEPC treated 
or Millipore water). The quantity of the isolated RNA was determined by photometric 
measurement. The quality was monitored by electrophoresis on an agarose gel 
stained with ethidium bromide: two distinguishable bands of 28S and 18S ribosomal 
RNA (~5kb and ~2kb respectively) were visible, which provided test for the sufficient 
amount of total RNA. 
2.2.2 Reverse transcription 
The Super Script III First-Strand Synthesis System (Invitrogen) for the cDNA 
synthesis from mRNA template was used following manufacturer protocol. 3 to 5 µg 
of total RNA was mixed with Oligo(dT)20 primer or gene specific primer (GSP) and 
dNTPs. Mixture was heated and cooled down for primer annealing. cDNA Synthesis 
mixture containing 10X transcription buffer, 25mM MgCl2, 0.1M DTT, 40U of 
RNaseOUT and 200U of SuperScript III RT was added to RNA mix. cDNA synthesis 
was performed at 500C for 50 min in 20µl reaction volume and terminated by heating 
at 850C for 5 min. To remove RNA template 1µl of RNAseH was added to the 
sample for 20 min (370C).  After the synthesis, 2µl of the reaction product was used 
for PCR.  
2.2.3 5’ RACE 
This method allows to amplify full-length transcripts via elimination of truncated 
mRNA from the amplification process (Maruyama and Sugano, 1994; Schaefer, 
1995; Volloch et al., 1994. Fig. 6). At first step purified total RNA from E16.5 limbs is 
treated with calf intestinal phosphatase (CIP). This enzyme removes 5’ phosphate 
group from truncated RNA and non-mRNA (but has no effect on full length, capped 
mRNA), thus allowing to prevent subsequent ligation with the GeneRacerRNA Oligo. 
The dephosphorylated RNA is treated with tobacco acid pyrophosphatase (TAP) to 
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remove the 5’cap structure from the full-length mRNA. This enzyme leaves a 
5’phosphate required for ligation to the GeneRacerRNA Oligo. The GeneRacerRNA 
Oligo is then ligated to the 5’end of the mRNA using T4 RNA ligase. Ligated mRNA 
was reverse-transcribed to create RACE-ready first-strand cDNA with known priming 
site at 5’ end. To amplify the 5’ ends of cDNA a reverse gene specific primer (GSP) 
and GeneRacer 5’Primer (complementary to the GeneRacerRNA Oligo) were used. 
Additionally, gene specific nested primers (NGSP) are used to amplify the 5’ cDNA 
end. Control primers, complementary to the 3’region of the Tmem16f gene were 
used to confirm presence and sufficient amount of the cDNA. Several clones, 
obtained from the 5’RACE were chosen for the sequencing. 
 
Primers for the amplification of the 5’ part of Tmem16f: 
 
GSP1 (complimentary to the 5’-end of the Tmem16f)  
5’- GATAAGGTTAGATTCGTATGCTTGTC-3’ 
NGSP1 (complimentary to the 5’-end of the Tmem16f) 
5’-GTTCAGCAGGACCTTCCTAGTCATC -3’ 
GeneRacer RNA Oligo 
5’- CGACUGGAGCACGAGGACACUGACAUGGACUGAAGGAGUAGAAA -3’ 
GeneRacer 5’Primer         5’-CGACTGGAGCACGAGGACACTGA-3’ 
 
Control Primers to the 3’ region of Tmem16f cDNA 
contr_fw                            5’-ACCCCACGATGGGAACAGGATTACC-3’ 
contr_rev                           5’-TCGGAAGTCACGGTACCTGCACAAG-3’ 
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Figure 6: Scheme of the 5’ RACE. 
Accepted from “GeneRacertm Kit” manual, Invitrogen. 
 
2.2.4 Proof of the Tmem16f cDNA  
Primers for different Tmem16f exons were used in PCR to confirm intron-exon 
structure of the Tmem16f gene: 
Exon-3                               5’-AGCAGGACTTCAGGACTCCA-3’ 
Exon-6                               5’-AGTGCTGTGCACCTATGCTG-3’ 
Exon-8                               5’-AGGGAACGCTGCTTTGTAGA-3’ 
Exon-11a                           5’-CGAAGATCAGGGTTCCAAAA-3’ 
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Exon-11b                           5’-TTTTGGAACCCTGATCTTCG-3’ 
Exon-16                             5’-CGTCAGCTGTGTGGTCAGTT-3’ 
2.2.5 Preparation of genomic DNA from mammalian tissue 
Mouse liver (500mg up to 3g) was rapidly frozen in liquid nitrogen and crushed to 
produce readily digestible pieces. It was important to avoid taking gallbladder, since 
it contains high levels of degradative enzymes. The tissue was suspended with 2ml 
of solution A (25mMEDTA pH8.0, 75 mM NaCl) per each 500mg of tissue, followed 
by the addition of 2ml of solution B (10 mM EDTA pH8.0, 10 mM Tris-HCl pH 8.0, 
1% SDS (w/v), 400 µg/ml Proteinase K) for the same amount of tissue. Digestion by 
Proteinase K took place overnight at 550C in water bath on a shaking platform. After 
that 2ml of solution A and 2 ml of solution B were added to the suspension and 
incubated for 2 hours at 550C to allow most of the cellular proteins to degrade. In 
order to remove RNA, 10 µl of RNAseA (stock solution 10mg/ml) was added per 2 ml 
suspension and incubated for 1 hour at 37oC. Phenol/chloroform extraction was 
performed twice with gentle rotation of the tube using equal volume of reagents and 
slow centrifugation at 5000rpm for 10min helped to remove proteins from the DNA. 
DNA was precipitated from the aqueous phase by adding 5M NaCl (to final 
concentration of 250mM) and 0.7V isopropanol. DNA became visible as a white 
“threads” after gentle rotation of the mix and could be easily removed from the 
solution by a glass stick. DNA was placed into clean eppendorf tube, dried, and left 
overnight in 250 µl of water or TE-buffer at 40C to dissolve. The quality of genomic 
DNA was analysed by gel electrophoresis and the quantity was measured with a 
photometer (Pharmacia Biotech). This quantity can be also estimated by the 
A260/A280 ratio. Ratio >1.8 shows highly pure DNA, while 50%protein/50%DNA 
mixtures have A260/A280 ratios of ~1.5.  
2.2.6 Southern Blot: DNA transferring onto a nylon membrane with high-salt 
buffer 
Southern Blotting is the transfer of DNA fragments from an electroforesis gel to a 
membrane support (Southern, 1975). The protocol is divided into three stages. First, 
the agarose gel is pretreated by soaking in a series of solutions that depurinate, 
denature, and neutralize the DNA and gel matrix. The second stage is the transfer 
itself, which occurs by upward capillary action. Third, the DNA is immobilized on the 
membrane by UV irradiation (Ausubel et al., 1987-1999).  
Preparation of the gel 
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Genomic DNA was digested with appropriate restriction enzyme. The mixture 
contained 5 to 15 µl of genomic DNA in 30 to 50µl volume, 20 to 40 U of restriction 
enzyme, 0.1mM DTT, 1mM Spermidine and 100µg/ml BSA. After 2 hours of 
incubation another portion of the restriction enzyme was added to complete 
digestion.  The sample was incubated for another 2 to 4 hours. 0.8% agarose gel 
was run in 0.5 X TBE buffer overnight with appropriate DNA size markers, stained 
with ethidium bromide. The gel was photographed with a ruler laid alongside so that 
band positions can later be identified on the membrane. Then the gel was rinsed in 
distilled water, placed in a clean glass dish containing ~10 gel volumes of 0.2 N HCl 
and shaken slowly for 30 min. This partial depurinization of the DNA fragments led to 
strand cleavage and thus to the length reduction, which improves the transfer of 
longer molecules. After depurinization the gel was placed in ~10 volumes of 
denaturation solution (1.5M NaCl/ 0.5N NaOH) for 45 min to 1 hour. Denaturation 
gives single stranded molecules which are suitable for subsequent hybridization. For 
neutralization the gel was placed in 1.5M NaCl/1M Tris (pH 7.4) solution to bring the 
gel pH down to <9.0.  
Set up the transfer 
Transfer buffer (10 X SSC) was put into reservoir of an appropriate size. The glass 
plate with a sheet of long 3MM Whatman filter paper (soaked in 10 X SSC) was 
placed on to the reservoir so, that the ends of the filter paper were submerged into 
transfer buffer. Another couple of short sheets of Whatman paper (slightly larger than 
the gel) soaked in 10 X SSC was placed onto the glass plate. Air bubbles were 
carefully removed from the paper sheets. The gel was placed onto the sheets and 
covered with the nylon membrane (Hybond) soaked in 6XSSC. The membrane was 
the same size as the gel.  3 more pieces of Whatman paper were placed on the 
nylon membrane, soaked into 6 X SSC. Four strips of plastic wrap were placed over 
the edges of the gel to prevent the buffer from “short-circuiting”. Paper towels were 
placed on Whatman sheets and a weight of 0.3-0.4 kg was placed on a top of them. 
The transfer took place overnight. After the transfer, the position of the slots was 
marked on the filter and the same bottom corner was cut as on the gel to distinguish 
the direction of the membrane later.  
Immobilization of the DNA: UV crosslinking 
Nylon membrane was shortly rinsed in 6 X SSC and completely dried on Whatman 
Paper. DNA crosslinking was performed at 245-nm wavelength in Stratalinker 
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(Stratagene). UV crosslinking leads to covalent attachment and enables the 
membrane to be reprobed several times. 
2.2.7 Preparing the radioactive labeled probe for hybridization 
Procedure was performed using Rediprime II Random Prime Labelling System 
(Amersham), based on the method, introduced by Feinberg and Vogelstein 
(Feinberg and Vogelstein, 1983 and 1984). Following the manufactures protocol, 
DNA for hybridization was diluted to a concentration of 25ng in 45µl of TE-buffer 
(10mM Tris HCl pH 8.0, 1mM EDTA), denaturated at 950C for 5 min and cooled 
immediately by placing on ice for 5min after denaturation. Denatured DNA and 5µl of 
Redivue [32P]dCTP were added to the reaction tube (pre-made by manufacturer) and 
mixed well by pipetting. Reaction was incubated at 37oC for 1 hour. Addition of 5µl of 
250mM EDTA stopped the reaction and the probe was cleaned using micro spin 
columns (Amerscham) following manufactures protocol. 500µl of hybridization buffer 
(Church buffer containing fish sperm DNA (0.1 µg/ml) and Cot-DNA (500µg/ml) was 
added to the cleaned DNA probe. The mixture was heated at 950C for 5 min to 
denaturate DNA probe and added directly to the membrane in preheated 
hybridization buffer. Fish sperm DNA and mouse Cot-DNA serve to prevent non-
specific binding of DNA-probe by annealing to nonspecific sequences and repetitive 
elements. 
 
2.2.8 Southern Blot hybridization 
Nylon membrane carrying digested genomic DNA was prehybridized in 15-20 ml of 
hybridization buffer for 6 hours or overnight at 65oC. The solution was changed to 
the 5ml of hybridization solution with radioactive labeled probe (Church buffer+ fish 
sperm DNA+ Cot-DNA+ labeled DNA probe). Hybridization took place overnight at 
65oC, followed by 3 step- washing: 30 min at 65oC in 200 ml of solution I, 30 min at 
65oC in 200-300 ml of wash solution II, two times.  The phosphoimager cassette was 
exposed overnight to the wet filters packed in to the plastic foil.  
2.2.9 PAC library hybridization 
Mouse genomic PAC library (RPCI21 High Density Gridded Filters) was used.  
The source of the library was the female 129/SvevTACfBr mouse spleen genomic 
DNA. Seven filters PAC1 to PAC7 covered the whole library. Each filter was 
prehybridized in 100 ml of hybridization buffer at 65oC overnight. Prehybridization 
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solution was removed and 30ml hybridization solution containing labeled probe was 
added immediately. Hybridization took place at 650C overnight. Filters were washed 
in three steps. The first wash in 200ml of solution I was performed for 30min at 65oC 
followed by the second and third washes in 500 ml of solution II for 30 min at 65oC.  
 
Primers for the amplification of the 714bp DNA-probe: 
Primer1_fw                       5’-GGGAGACATGCAGATGATGA-3’ 
Primer1_rev                      5’-GGTGCAGAGCCTTAACTTGC-3’ 
2.2.10 Tmem16f gene targeting 
The targeting vector for Tmem16f gene was electroporated into R1 ES cells (derived 
from 129/Sv mice). These cells were subsequently grown in the presence of 
Geneticin (G418). Resultant colonies were isolated, expanded, and further analyzed 
by Southern blot hybridization for the correct integration site. ES cells of chosen 
clones were injected into the blastocysts from black C57Bl/6J mice. The injected 
blastocysts are transfered into the uterus of foster mice, where they develop into 
chimeric mice. Germ-line transmission was recognized by mating these chimeric 
mice to C57Bl/6J mice. ES-cell-derived germ cells result in agouti animal, since 
agouti is dominant over black. 
  
2.2.11 ES cell clones analysis 
The analysis of 360 ES cell clones was performed by Southern blot hybridization 
using 5’- and 3’- external probes (Fig. n+1). Genomic DNA purified from the ES cell 
clones was digested in a total volume of 30µl with 40 units of appropriate restriction 
enzyme. Incubation took place at least 6 hours at the optimal condition for given 
enzyme. 120 ES cell clones were analyzed on one filter. Each filter was 
prehybridized in 90 ml of hybridization solution. 20 ml of hybridization solution 
containing 2 radioactive labeled probes was used for this hybridization. The two-
steps washing routine was performed at 65oC for 30 min (washing solution I) and at 
55oC for 10 min (solution II). 
 
Primers for the 5’ probe: 
ST2-5‘probe5‘                   5'-CCTAGAACATGCCCTTCAGATAC-3' 
ST2-5‘probe3‘                   5'-TCCAGTATGGTGAGCCAGTGAG-3' 
Primers for the 3’ probe: 
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3‘ES_ST2_fw                    5'-AAA TGC ACG CAA GAT TAT GCT-3' 
3‘ES_ST2_rev                   5'-ACT GGA CCT GGA AAC CTG AAA G-3' 
2.2.12 Cloning techniques  
2.2.12.1 PCR 
Polymerase chain reaction was performed in 25-50µl volume mixture containing 
1XPCR Buffer, two primers 0.5µM each, 200µM dNTPs mix, 10-100ng DNA 
template, 2.5U of Taq-polymerase. 30 cycles were used to amplify the DNA 
fragment.  
2.2.12.2 Restriction digestion 
To digest DNA, chosen restriction enzyme was added in a ratio 1U of enzyme to 1 
µg of DNA in 50µl of reaction. Buffer and temperature condition were used according 
the manufacturer data (NEB). 
 
2.2.12.3 Ligation 
Reaction was performed at 16oC or room temperature for 4 to 16 hours. 10µl of 
reaction mixture contained 10X ligation buffer, 5mM DTT, ~100ng of the fragment, 
~50ng of the vector and 1 U of the T4-DNA ligase (Roche). The ligase was 
inactivated by heating at 65oC for 10min.  
2.2.12.4 Transformation 
Heat-shock competent cells (Invitrogen) were used followed manufacturer protocol. 
An aliquot of the cells (50µl) was thawed on ice and 1-3 µl of the ligation mix were 
added to the cells. After 30 min of the incubation on ice the cells were placed into 
37oC water bath for 30 seconds and then immediately on ice. 1 ml of SOC-medium 
was added to the cells and incubated for 1 hour at 37oC on shaking platform. 
Different amount of the suspension (5, 50 or 200µl) was plated onto agar-plate 
containing an appropriate antibiotic for the clone-selection. 
2.2.12.5 Clone analysis 
To pick up the right clone, containing correct sequence of DNA fragment, up to 60 
clones were analyzed. The analysis was performed by colony-PCR and restriction 
digestion.  
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2.2.12.6 DNA sequencing  
The sequencing of DNA was performed by Seqlab (Sequence Laboratories 
Göttingen GmbH), Göttingen. 
2.2.12.7 Cloning of Tmem16f into pEGFP-N3 vector 
The small fragment of the 3’end (~300bp) of the Tmem16f gene was amplified and 
inserted in to the pEGFP-N3 plasmid, digested with KpnI and BamHI restriction 
enzymes 
 
Primers: 
CTD_KpnI                        5’-CTTGTGCAGGTACCGTGACTTCC-3’ 
CTD_BamHI                    5’-AAATGGATCCTTCGAGTTTTGGC-3’ 
Larger 5’ part of the gene was cut out from the RZPD clone, containing most of the 
Tmem16f cDNA sequence. The EcoRI- KpnI fragment was inserted into pEGFP-N3 
infront of the cloned 3’part of Tmem16f ORF. 
Sequences in bold represent sites of restriction enzymes. 
2.2.12.8 Cloning strategy for ST2-C6 KO construct (in to pWH9) 
5’ arm cloning: 
XhoI primers were used for amplification of the 5’ arm sequence. Ligation with 
pWH9:XhoI  vector. Result: pWH9-ST2-5’arm construct 
 
Primer sequences: 
ST2-5‘arm5‘                       5'-GAAAACTCGAGTGGAGCTGTTACTTGG-3' 
5’armST2_XhoI_1             5'-AAAACTCGAGCTTCTATGAGCTCACGAGGGTC-3' 
 
3’ arm cloning was done in two steps: 
Step I: cloning of the 3’ arm in to pBS II SK in 2 pieces: 
1) SalI-BamHI fragment (4,3 kb PCR-product) 
 
Primer sequences: 
ST2_3’arm _SalI              5'-AAATTGTCGACTGAGCTGTCTGTAACTTGGGA-3' 
ST2_3’arm BamHI_rev    5'-TATTTGGATCCAAAGCATCAAGAAGAGAGAATGAG-
3' 
2) BamHI-XbaI PCR-fragment (3,58 kb) 
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Primer sequences: 
3’armST2_BamHI_fw       5'-GCTTTGGATCCAGATGTAGAACTCTCAGTTCCTTC-3' 
3’armST2_XbaI                5'-TCACATCTAGAATACAAACTGCACCAAAGGTGG-3' 
 
Step II: subcloning of the 3’arm fragment from pBS II SK vector into pWH9-ST2-
5’arm construct using SalI & NotI enzymes 
2.2.12.9 Preparation of the murine Tmem16f-probe for the in situ hybridization 
 
Primer sequences 
BamH I_1ex5’                   5'-AAAGGATCCTCGCACGCTGAGCAGCGCCTG-3' 
EcoR I_1ex3’                    5'-AAAGAATTCCAATGTCTCCATCCTCATCG-3' 
PCR fragment of 220bp was cloned into pBS K II 
 
2.2.13 Genomic DNA preparation from mouse tail 
Piece of mouse tail was placed in 500 µl of lysis buffer (50 mM Tris-HCl, pH 8.0, 
100mM EDTA, 1% SDS, 100 mM NaCl) with 10 µl of 20 mg/ml proteinase K in 1.5 ml 
tube and incubated at 55°C overnight. The mixture was cooled down to room 
temperature and 250 µl of 5 M NaCl was added. Then, the mixture was shaken and 
incubated for 10 minutes on ice. Probes were centrifuged at 8,000 rpm for 8 minutes. 
Supernatant (0.5 ml) was transferred to the clean tube and DNA was precipitated by 
addition of 1 ml of 100% ethanol followed by centrifugation at 14,000 rpm for 10 
minutes at room temperature. DNA pellet was resuspended in 70-100 µl of TE buffer 
at 65°C for 20 minutes. 
2.2.14 Genotyping of the mice 
Genotyping of the mice was performed by PCR. PCR mixture contained 100 ng 
genomic DNA, 0.02 µM of appropriate primers, 0.25 mM dNTPs, 0.5 U Taq-
polymerase and 10x PCR-buffer.  
 
Primers for Col II-Gal4 mice 
forward primer            5'-CTTCTATCGAACAAGCATGCG-3' 
reverse primer            5'-GCCAATCTATCTGTGACGGC-3' 
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The PCR conditions for genotyping of ColII-Gal4 mice were: 94oC for 5 minutes; 
40 cycles of 94oC for 30 seconds, 58oC for 30 seconds, 72oC for 30 seconds; and 
72oC for 5 minutes.  
The resulting fragment of 322bp indicated a transgenic mouse. 
 
Primers for UAS-Ihh mice  
forward primer           5'-GGGCGGGCGCTGGCGACGCTG-3'  
reverse primer                  5'-CGGGCTGCACGTGGCTG-3' 
The PCR conditions for genotyping of UAS-Ihh mice were: 94oC for 10 minutes; 
35 cycles of 94oC for 30 seconds, 72oC for 30 seconds, 72oC 30 seconds; and 72oC 
for 10 minutes.  
The resulting fragment of 300 bp indicated a transgenic mouse. 
 
Primers for Ihh deficient mice 
Neo                                   5´-TACCGGTGGATGTGGAATGTGTGCG-3´ 
Ihh- fw                               5´-AGGAGGCAGGGACATGGATAGGGTG-3´ 
mIhh ex2 rv2                     5’-TGTTCTCCTCGTCCTTGAAGA-3’ 
The PCR conditions for the wild -type allele were: 94°C for 5 minutes; 32 cycles of 
94°C for 45 seconds, 59°C for 45 seconds, 72°C for 60 seconds; and 72°C for 7 
minutes. The resulting 160 bp fragment indicated the wild-type allele. For genotyping 
of the transgenic allele the following PCR conditions were used to amplify a 300 bp 
fragment: 94°C for 5 minutes; 30 cycles of 94°C for 1 minute, 62°C for 1 minute, 
72°C for 1 minute and 72°C for 7 minutes. 
 
Primers for Runx2 deficient mice 
runx2neo                          5’-TCTGGATTCATCGACTGTGG-3’ 
CBFA11fw                        5’-CTTGAAGGCCACGGGCAGG-3’ 
MCBFA                            5’-CAAGATGAGCGACGTGAGCC-3’ 
The PCR conditions were: 94oC for 5min, 5 cycles of 94oC for 1 min, 64oC for 45 
sec, 72oC for 45 sec; 10 cycles of 94oC for 1 min, 62oC for 45 sec, 72oC for 45 sec; 
20 cycles of 94oC for 1 min, 60oC for 45 sec, 72oC for 45 sec; and 72oC for 7 
minutes. 
The resulting fragment of 450 bp indicated a transgenic allele and the fragment of 
320 bp indicated the wild type allele. 
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Primers for Tmem16f deficient mice 
neo-3’fw_3                        5’-CCTTCTATCGCCTTCTTGAC-3’ 
ST-3’arm_rev_5                5’-CTCCTCCTTACTTCTAAGACATC-3’ 
The PCR conditions were: 95oC for 5min, 30cycles of 95oC for 30sec, 58oC for 30 
sec, 72oC for 30 sec, final elongation 72oC for 5min. The resulting 600bp fragment 
indicated transgenic allele. 
 
Primers for Tmem16f wild type mice 
ST2_wt_fw primer             5’-TTCTCTGTCCTCTTTCGGT- 3’ 
3’arm_rev_2                      5’-GACTTACACTATACTCGACA- 3’ 
The PCR conditions were: 95oC for 5min, 30cycles of 95oC for 30sec, 58oC for 30 
sec, 72oC for 40 sec, final elongation 72oC for 5min. The resulting 600bp fragment 
indicated wild type allele. 
 
Primers for Tmem16f gene trap cassette 
ST2-ex13_gtreseq            5'-GGT CAC GCT GTG TGC GAG C-3' 
GT-vec-70-R                     5‘-CAC TCC AAC CTC CGC AAA CTC-3‘ 
The PCR conditions were: 95oC for 5min, 30cycles of 95oC for 30sec, 61oC for 30 
sec, 72oC for 30 sec, final elongation 72oC for 5min. The resulting ~300bp indicated 
gene trap allele. 
 
Primers for Tmem16f gene trap wild type mice 
ST2-ex13_gtreseq            5'-GGT CAC GCT GTG TGC GAG C-3' 
gt-wt-rev_3primer              5‘-GCAATACTCCACGTGACAG-3‘ 
The PCR conditions were: 95oC for 5min, 30cycles of 95oC for 30sec, 55oC for 30 
sec, 72oC for 25 sec, final elongation 72oC for 5min. The resulting ~300bp indicated 
wild type allele. 
2.2.15 In situ hybridization 
2.2.15.1 Preparation of DNA template for in vitro transcription 
Plasmid DNA was isolated from E.coli DH5 cells using QIAprep Plasmid Miniprep 
according to the manufacturer instructions. 5 µg of plasmid DNA was linearized with 
5 U of the appropriate restriction endonuclease for 1 hour at the optimal temperature. 
Efficiency of the digestion was analyzed on a 1% agarose gel. Phenol/chloroform 
extraction was performed twice. The final aqueous phase was transferred to a clean 
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tube and was precipitated with 2.5 volumes of 100% ethanol. The mixture was 
centrifuged at 14.000 rpm for 15 minutes at 4oC. The DNA pellet was washed with 
cold 80% ethanol and resuspended in 10 µl of RNAse free water. 
2.2.15.2 Labeling of antisense riboprobes 
Transcription reaction was performed in 20 µl with the following components: 500 ng 
linearized DNA template for in vitro transcription, 1x transcription buffer, 0.5 mM NTP 
mixture, 5 U RNAse inhibitor, RNAse free water, 40 U RNA-polymerase and 80 µCi 
[P33]-UTP. The transcription reaction was carried out for 1.5 hours at 37°C. To 
remove the DNA template, 20 U of DNAse (RNAse-free) were added to the 
transcription mixture and incubated for 20 minutes at 37°C. The transcription mixture 
was then diluted with 4 volumes of RNAse free water, containing 20 ng/ml glycogen 
and 0.5 M LiCl, and precipitated with 2.5 volumes of 100% ethanol. Probes were 
incubated at -20°C for 30 min and then centrifuged at 14000 rpm for 15 minutes at 
4°C. The RNA pellet was washed with cold 75% ethanol, resuspended in 50µl 
RNAse free water, and diluted with 1ml of hybridization buffer. The riboprobe was 
heated for 5 minutes at 95°C (denaturation) and chilled on ice (kept on ice until 
used). 
2.2.15.3 Prehybridization and in situ hybridization 
All solutions for the prehybridization procedure were prepared with RNAse free 
water. The sections were incubated in xylol for 20 minutes to remove the paraffin. To 
rehydrate the tissue, the sections were incubated in a descending ethanol series 
(100%, 95%, 80%, 75%, 50%, 30%) each for 2 minutes, followed by 0.85% NaCl for 
5 minutes and PBS for 5 minutes. After rehydration the tissue was fixed in 4% PFA 
for 20 minutes. The sections were then incubated for 5 minutes in following 
solutions: PBS, 0.2N HCl and RNAse free water. The tissue was digested for 5 
minutes with 0.02 mg/ml Proteinase K and rinsed with PBS for 5 minutes. 
Subsequently the sections were refixed in 4% PFA with 0.2% glutaraldehyde for 10 
minutes and rinsed with PBS for 5 minutes. The sections were incubated in 0.2% 
Triethanolamine with freshly added 0.25% acetic anhydride for 10 minutes, then 
rinsed with PBS for 5 minutes and additionally incubated in 0.85% NaCl for 5 
minutes. Sections were dehydrated with the following ethanol solutions: 30%, 50%, 
75%, 100%. The sections dried at RT for at least 15 minutes. A minimal volume of 
labeled riboprobe (50 µl) was distributed evenly on the slide and the sections were 
covered with plastic coverslips to prevent evaporation. Hybridization was performed 
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at 70°C overnight. 
2.2.15.4 Washing of slides and dipping in photoemulsion 
After hybridization the sections were washed in 5xSSC for 30 minutes at 55oC and 
coverslips were removed from the slides. The sections were washed in 2xSSC for 30 
minutes at 55oC, followed by treatment with 0.02mg of RNAse A in 1x Washing 
buffer for 30 minutes at 37oC. Stringent washing procedure was performed in 2xSSC 
with 50% formamide for 30 minutes at 55oC followed by washing in 2xSSC for 30 
minutes at 55oC twice. The sections were dehydrated in an ascending ethanol series 
(30%, 50%, 75%, 80%) containing 0.3M ammonium acetate. Finally, the sections 
were briefly incubated in 100% ethanol and dried for 10 minutes at RT. X-ray film 
(Kodak Scientific Imaging Film) was placed on the slides for overnight exposition at 
RT to estimate the intensity and the signal strength of each probe. The sections were 
dipped into photoemulsion NTB2 at 42°C in the darkness. Dried sections were stored 
at 4°C in darkness for the time predicted from the developed X-ray film. The dipped 
sections were developed using Kodak-developer for 5 minutes at 15°C, rinsed in 
water and fixed in Kodak-fixer for 15 minutes at RT. The sections were 
counterstained with 0.2% Toluidin blue O and dehydrated in ethanol solutions 30%, 
50%, 75%, 80%, 95% and 100%. The sections were placed into 100% xylol for at 
least 20 min and then covered with glass coverslips using minimal volume of 
mounting medium (DPX mountant for histology). The slides were dried overnight. 
The sections were analyzed and photographed by dark-field microscopy.  
2.2.16 The gene trap integration site 
The integration site for the gene trap cassette was initially defined by Bay Genomics 
as approximate site of cassette insertion. To confirm this data the integration site 
was proven by PCR with the primers annealed at the end of exon 13 of Tmem16f 
and to the gene trap cassette. The sequence of PCR product confirmed integration 
of the cassette into 13th intron, 300b.p. beyond the exon 13. The same pair of 
primers was used for the genotyping of the gene trap mice. 
2.2.17 Alcian Blue-Alizarin Red staining 
Embryos or adult mice were dissected and skin and fat were carefully removed. The 
specimens were fixed in 95% Ethanol for 3 days and placed in acetone for one day 
to remove the rest of the fat. Acetone was removed and specimens were washed 
with 95% ethanol. Ethanol was replaced by Alcian Blue solution for one day at room 
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temperature. Alcian Blue solution was replaced with 95% ethanol for one day 
followed by replacement with Alizarin Red solution. The skeletons were stained for 1 
day with Alizarin Red followed by the clearance with 1% KOH (for the embryos) or 
2% KOH (for adult mice) for one to two days. The specimens were placed in 20% 
glycerol/1%KOH (2% KOH for adult specimens) until they were cleared. For longer 
storage the skeletons were placed in 40% glycerol/1%KOH followed by the 60% 
glycerol /1%KOH, 80% glycerol /1%KOH and finally 100% glycerol (at least one day 
for each solution). Alcian Blue stains cartilage in blue and Alizarin Red stains bone in 
red. 
2.2.18 X-gal staining 
The E. coli lacZ gene encoding ß-Galactosidase (ß-Gal) is the classical 
histochemical reporter gene. The activity of ß-Gal can be detected by X-gal (5-
bromo-4-chloro-3-indolyl-ß-D-galactoside). X-gal staining is used to detect ß-
galactosidase activity in transgenic mice. E14.5 or E15.5 embryos were put into the 
fixing solution for 30min at 4oC, cut in two pieces, washed with 1XPBS and 
incubated further in fixing solution for another 30min. The embryos were washed two 
times in 1X PBS for 20min at room temperature. PBS solution was removed and 
staining solution was added followed by the incubation for one to two days at 30oC. 
After staining the samples were stored in 1X PBS for several days while 
photographing.  
2.2.19 Von Kossa staining  
The von Kossa technique is a histochemical method for detection of calcium, 
associated with phosphate and carbonate (Kiernan, 2008).  The reaction is carried 
out in bright light (or UV light), which leads to reduction to metal of silver ions in the 
crystals of the insoluble silver phosphate and carbonate. Unreduced ionized silver is 
removed by treatment with sodium thiosulphate followed by subsequent 
counterstaining for the nuclei of the cells. In more details, the paraffin sections were 
deparaffinized and rehydrated to water through the descending ethanol raw and 
rinsed several times in distilled water. The sections were incubated with 1% silver 
nitrate in clear glass coplin jar for 20 min under UV light. The slides were rinsed 
several times with distilled water and un-reacted silver was removed by 5% sodium 
thiosulfate for 5min. The sections were rinsed with distilled water and counterstained 
with Nuclear Fast Red for 5min. Slides were rinsed with water and then dehydrated 
through the ascending ethanol and placed in Xylol. The slides were covered using 
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DPX mounting medium. Calcium salts can be visualized as black or dark brown 
precipitate and nuclei are stained in red or pink.  
2.2.20 Hematoxylin Eosin staining 
This histological staining method stains nuclei blue (Hematoxylin) and the cytoplasm 
red (Eosin). Sections were deparaffinized, rehydrated and subsequently incubated 
for 45seconds in Hematoxylin, rinsed shortly with tap water and then incubated for 2 
to 3 minutes in Eosin. Finally slides were rinsed with tap water, dehydrated by an 
increasing ethanol series, transferred into Xylol and embedded in DPX mounting 
medium. 
2.2.21 TRAP staining 
The tartrate resistant acid phosphatase (TRAP) is the marker for the osteoclasts. 
Compared to other nonspecific phosphatases, this enzyme has optimal activity in 
acidic conditions (pH<5) and can be distinguished from other phosphatases by its 
resistance to inhibition by tartrate. Naphtol AS-BI, released by enzymatic hydrolysis, 
couples immediately with fast garnet GBC forming insoluble dark-red dye deposits at 
sites of activity. The acid phosphatase kit (Sigma) was used for osteoclasts 
detection, following manufacturer protocol. In brief, the sections were fixed in 
Citrate/Aceton solution for 30sec at room temperature, rinsed in deionized water and 
dried at least for 15 min. The staining solution was prepared by mixing water, 
Acetate solution, Naphthol AS-BI phosphoric acid and Tartrate solution. Contents of 
one capsule Fast Garnet GBS salt was added to the mixture, and prepared solution 
was finally filtered through Whatman No. 54 paper. The solution was placed in the 
37oC water bath until it reaches the same temperature. The samples were incubated 
in the staining solution for 1 hour at 37oC in dark. The slides were washed in 
deionized water, counterstained in Acid Hematoxylin Solution for 5min, and dried 
before imbedding in the aqueous mounting medium.  
2.2.22 Preparation of the cryosections 
The limbs were embedded in to the O.C.T. medium (Optimal Cutting Temperature, 
Tissue Tek) at -40oC to -60oC. 10µM cryosections were done at -20oC and dried at 
room temperature for several hours. The tissue on slides was stored at -80oC if not 
used immediately. The tissue was fixed in acetone for 10 min at 4oC and washed in 
the buffer used for the appropriate staining or water. 
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2.2.23 Detection of Alkaline Phosphatase activity 
To detect the activity of Alkaline Phosphatase the 8µM cryostat sections of the 
forelimbs were fixed in acetone for 10 min at 4oC and rinsed with water. The tissue 
was stained using Alkaline Phosphatase (AP) kit from Sigma. 1ml of Sodium Nitrite 
Solution and 1ml of FBB-Alkaline Solution were mixed and incubated for 2min at 
room temperature. This mix was added to 45ml of the deionized water (forming 
diluted diazonium salt solution). 1ml of Naphtol AS-BI Alkaline Solution was added to 
the diluted diazonium salt solution. This alkaline-dye mixture was added to the fixed 
slides and incubated for 15min. After incubation the slides were rinsed for 2 minutes 
in deionized water and counterstained for another 2 minutes with Neutral Red 
solution, Buffered. The aqueous mounting media (Kaiser gelatine) was used for 
coverslipping.  
2.2.24 Transient transfection of COS-7 cells  
Approximately 4x104 of COS-7 cells were seeded the day before transfection on the 
round (15mm) glass coverslips laying on the bottom of the 12-well plate in 1ml of 
growth medium and incubated at 37oC and 5% CO2.  The cells were about 40-80% 
confluent before the transfection. 0.6 to 1.2µg of DNA was diluted in 40µl of DMEM 
without serum or antibiotics. 4µl of PolyFect Reagent was added, followed by mixing 
(vortexing) for 10sec. To allow complex formation, the mixture was incubated for 5-
10 min at room temperature. During the incubation, the COS-7cells were washed 
with PBS and growth medium was exchange for 600µl of new medium, containing 
serum and antibiotics. 250µl of serum- and antibiotic-containing growth medium were 
added to the DNA complex, mixed by pipetting, and transfered to the cells. The well-
plate was gently swirled to ensure uniform distribution of the complexes. Incubation 
took place for 24-48 hours at 37oC and 5%CO2. After incubation the cells were 
washed in 1X PBS and fixed in 4% PFA in 1X PBS for 15min at room temperature. 
The cells were washed 3 times with PBS and placed on the slide (coverslip upside-
down) with 7µl of Vectashield mounting medium for fluorescence, containing Dapi. 
Dapi stains the nuclei of the cells in blue, whereas GFP indicates the localization of 
the protein. The cells were then analyzed under fluorescent microscope with Dapi- 
and GFP-filters 
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Results 
3.1 Identification of the Tmem16f transcript structure 
3.1.1 EST clone sequencing 
In a screen for Ihh target genes an osteoblast-specific cDNA of 769 base pairs was 
discovered, which was a part of a novel protein-coding gene (Wenzel, 2003). This 
gene was later called Tmem16f or Anoctamin-6 (Ano6) (Kato and Katoh, 2004; 
Galindo and Vacquier, 2005). To identify the full cDNA sequence of 
Tmem16f/Anoctamin-6 we used BLAST algorithm of the NCBI database. We 
searched the Expressed Sequence Tag (EST) libraries for EST clones which aligned 
with the 769 bp sequence. Overlapping EST clones were then obtained from RZPD 
Deutsche Zentrum für Genomforschung GmbH. These clones were sequenced from 
the 5’ and 3’ ends and with new designed internal primers and thus new sequences 
aligned by DNA star program. Finally, we revealed a 5680 bp transcript of Tmem16f 
gene (Fig. 7). 
3.1.2 5’ RACE 
Although the 3’ end of the mRNA is readily verifiable due to the presence of the poly-
A tail sequence, it is not immediately obvious that the set of the overlapping ESTs 
really includes the 5’ end of the gene’s transcript sequence. To verify that we did not 
miss further extensions on the 5’ end we used the 5’RACE method (see chapter 
2.2.3). A total mRNA was purified from E 16.5 mouse limbs. GeneRacerRNA Oligo 
was ligated to the 5’-end of full-sequence mRNA. cDNA synthesis was performed 
from these templates with subsequent RT-PCR using specific primers to the 
GeneRacerRNA Oligo and gene specific primer (GSP) designed to match exon 5. 
Resulting fragments were cloned into the TOPO vector and sequenced (see chapter 
2.2.3). The results of the sequencing of the PCR product clones were aligned to the 
established cDNA sequence (Contig 2 on Fig.7). Eight clones exhibited perfect 
matches to the previously defined sequence, but none of them extended the 
previously assembled 5’ end of cDNA sequence. Two clones 23 and 29 revealed 
additional sequences, which were not homologous to the cDNA contig but were 
found to be homologous to sequences in the 1st intron of Tmem16f (shown in red on 
Fig. 8), and thus were attributed to alternative splicing of the second exon.  
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Figure 7: Assembly of the full length cDNA sequence. 
On the left side there are clones or consensus sequences which perfectly aligned to assemble a 
complete cDNA sequence of Tmem16f gene. “ST2C6-Full” is the sequence, fished from the screening 
for Ihh-target genes. “Contig2” is the resulting sequence, assembled from sequenced fragments of 
EST clones.  
 
These two clones (clone 29 and 23 (XM-178415-contig) contained additional 
sequences in the genomic region of the 1st intron of Tmem16f. They might then 
represent two potential alternative splicing variants of Tmem16f (Fig. 9).  
There were more ESTs and 5’RACE clones detected which did not contain the 2nd 
exon and only a few clones were found containing the 2nd exon. Therefore we 
conclude that Tmem16f transcript without exon 2 had by far the highest level of 
expression compared to the alternatively spliced variants with the 2nd exon. Because 
the gene-specific primer was inside the 5th exon, we could potentially detect splicing 
variations of exons 1, 3 and 4. We did not observe such variations. This indicates 
that exons 1, 3 and 4 are not alternatively spliced when exon 5 is present in 
Tmem16f (Fig. 9).  
 
Results 
46 
 
 
Figure 8: Alignment of the 5‘-RACE clones. 
On the left side: ccc- is the sequence received from sequenced EST clones, XM_178415 is a 
consensus obtained from computer Data Base, other names are for clones of the 5’-RACE 
experiment. Green marks Exon1, 2, 3 show start positions of the appropriate exons. ORF is the 
Tmem16f open reading frame. Sequences in red represent alternative spliced variants of exon 2 of 
Tmem16f.  
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Figure 9: Alternative splicing variants of Tmem16f. 
On the left side: clone 24 represents the majority of Tmem16f transcripts which skip second 
alternatively spliced exon. XM_178415 sequence represents the alternatively spliced exon 2a and 
clone 29 sequence represents the alternatively spliced exon 2b. Green signs Exon1, 2, 3, 4, 5 show 
the beginning of the appropriate exons. ORF is the Tmem16f open reading frame. Sequences in red 
represent alternative spliced variants of exon 2 of Tmem16f.  
3.1.3 Genomic organization of Tmem16f, transcript and protein structure 
Aligning the cDNA consensus region of the mouse gene to human EST libraries and 
subsequently comparing the protein-level homology of the corresponding human 
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sequence to the mouse Tmem16f protein, we were able to determine an ORF of 
2736 nucleotides in mouse Tmem16f encoding a protein of 911 amino acids. The 
Tmem16f gene consists of 21 exons (Table 11), where a fraction of transcripts 
undergoes alternative splicing of exon 2 (represent exon2a and 2b, based on XM-
178415 ESTs contig and 5’RACE results). The Tmem16f covers 184 kb of genomic 
sequence on chromosome 15 (Chr 15F1, nucleotides 95621274 to 95805180 of 
genomic sequence).  
 
Table 11: Genomic location of Tmem16f exons. 
Exon number Start End Exon length 
1 95,621,274 95,621,487 214 
2a 95,661,074 95,661,136 63 
2b 99,663,851 99,663,984 134 
3 95,694,656 95,694,738 83 
4 95,724,844 95,724,972 129 
5 95,742,736 95,742,801 66 
6 95,743,803 95,744,087 285 
7 95,744,303 95,744,416 114 
8 95,746,384 95,746,499 116 
9 95,750,675 95,750,809 135 
10 95,757,955 95,758,060 106 
11 95,762,214 95,762,274 61 
12 95,771,641 95,771,783 143 
13 95,773,829 95,773,906 78 
14 95,778,703 95,778,928 226 
15 95,779,922 95,780,091 170 
16 95,780,290 95,780,387 98 
17 95,786,322 95,786,452 131 
18 95,792,507 95,792,712 206 
19 95,796,252 95,796,454 203 
20 95,798,054 95,798,159 106 
21 95,802,926 95,805,180 2,255 
 
The open reading frame starts in exon 1 and ends in exon 21 of Tmem16f (Fig. 12). 
RT-PCR using primers complementary to the parts of different exons of Tmem16f 
confirmed the cDNA to be expressed (Fig. 10 A, C). Bioinformatics analysis 
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(ENSEMBL) revealed that the 3’ sequence of Tmem16f (exons 16 to 21) codes for a 
domain of Unknown Function (DUF 590, ENSEMBL ID IPR007632, Fig 10A, Table 
12). This domain was found to be highly conserved among different species such as 
human, rat, drosophila and C. elegans (NCBI-BLAST). 
 
Figure 10: Genomic structure of Tmem16f gene. 
Transcript structure of Tmem16f (A). Arrows show the position of the primers used in RT-PCR. Red 
underline shows the position of the DUF590 domain. Ano6-202 is a shorter isoform of Tmem16f (B). 
RT-PCR on cDNA derived from E16.5 mouse bone tissue with primers covering different regions of 
Tmem16f (C). M- marker, lanes 1, 2, 3- PCR products with primers covering exon 3 to exon 8, exon 6 
to exon 11a and exon 11b to exon 16 respectively. Contr- control primers were used to the fished 3’ 
region of Tmem16f (exon 17- exon 20).  
 
A shorter isoform of Tmem16f named Ano6-202 was predicted by Ensembl (Chr 
15F1, nucleotides 95773585 to 95805180 of genomic sequence). It represents the 
3’-sequence of Tmem16f containing exon13 to exon 21 of Tmem16f and an 
alternative spliced exon 12b on the 5’-end containing the start codon (nucleotides 
95,773,585 to 95,773,614 of genomic DNA) (Fig. 10B). Ano6-202 encodes a 
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polypeptide of 484 amino acid residues and contains the DUF 590 domain (from 
amino acid 182 to 446). The first nine amino acids of Ano6-202 do not match the 
sequence of Tmem16f protein.  
Tmem16f protein is a highly hydrophobic protein, which contains eight potential 
transmembrane domains predicted by the TMHMM algorithm (Table 12) 
(Sonnhammer et al., 1998; Krogh et al., 2001). The DUF domain is on the C-
terminus end of Tmem16f protein (from amino acid residue 609 to 873). Ano6-202 
predicted protein represents the shorter version of Tmem16f protein. It contains only 
6 transmembrane domains. The DUF domain is also fully represented in Ano6-202 
(Table 12).  
 
Table 12: Predicted domains of Tmem16f and Ano6-202 proteins. 
Tmem16f domains Position  Ano6-202 domains Position 
Transmembrane domain 1 296-316   
Transmembrane domain 2 377-397   
Transmembrane domain 3 456-476 Transmembrane domain 1 32-54 
Transmembrane domain 4 515-535 Transmembrane domain 2 79-101 
Transmembrane domain 5 553-573 Transmembrane domain 3 129-146 
Transmembrane domain 6 671-691 Transmembrane domain 4 245-267 
Transmembrane domain 7 727-747 Transmembrane domain 5 295-317 
Transmembrane domain 8 826-846 Transmembrane domain 6 399-421 
DUF 590  609-873 DUF 590 182-446 
 
Another prediction from TMHMM is that if Tmem16f is plasma membrane protein 
with both, the N- and C-terminal ends of the protein, exposed to the cytoplasm (Fig. 
11). The transmembrane domains 6, 7 and 8 are part of the DUF590 domain. Using 
the UniProt database six predicted N-linked glycosylation sites were found at the 
amino acid residues 330, 362, 494, 778, 785 and 803 which might be identified in  
extracellular loops of Tmem16f (Fig. 11).  
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Figure 11: Prediction of transmembrane domains and membrane orientation of 
Tmem16f. 
Blue and pink lines represent protein backbone, facing inside or outside the membrane, respectively. 
Regions in red represent the potential transmembrane regions of Tmem16f protein. Green asterisks 
show the predicted glycosylation sites present in extracellular loops. 
3.2 Expression analysis of Tmem16f 
To analyze the expression pattern of Tmem16f during embryonic mouse 
development, a P33-labeled antisense riboprobe complementary to the 1st exon of 
Tmem16f was hybridized on the sections of E14.5 and E16.5 wild-type mouse 
embryos (Fig. 12 B). As Tmem16f had initially been identified in a screen for Ihh 
target genes, it was further important to know if Tmem16f and Ihh are expressed in 
the same or adjacent tissues. To compare the expression domains of Tmem16f and 
Ihh, an antisense riboprobe to Ihh was hybridized on parallel sections. Ihh is 
expressed in prehypertrophic chondrocytes of endochondral bones such as bones of 
vertebrae and long bones of the limbs and ribs (Fig. 12 A and Fig. 13 A). Tmem16f 
was specifically expressed by the osteoblasts in the bone and periosteum 
surrounding the Ihh expressing domains (Fig. 12 B and Fig. 13 E).  
Further we analyzed expression of Tmem16f in different mutant mouse lines, which 
have bone malformations.  
It has been shown that in Ihh-deficient mice no endochondral bone is formed 
indicating that Indian hedgehog is essential for endochondral ossification (St-
Jacques et al., 1999). 
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Figure 12: Expression of Tmem16f. 
Longitudinal sections of wild type mice at E16.5 were hybridized with antisense riboprobes for Ihh (A) 
and Tmem16f (B). Ihh is expressed in the cartilage (A, red arrow), whereas Tmem16f is expressed in 
the bone and periosteum (B, red arrows).  
 
To analyze if Tmem16f acts downstream of Ihh the Tmem16f riboprobe was 
hybridized on the sections of E 16.5 mouse limbs of Ihh deficient mice and of mice 
expressing Ihh under Coll II promoter (Coll-II/Ihh mouse line). No expression of 
Tmem16f was detected in Ihh deficient mice (Fig. 13 C, G). In Ihh-overexpressing 
mice the expression of Tmem16f was expanded adjacent to Ihh domain (Fig. 13 B, 
F). These results show that Tmem16f acts downstream of Ihh.  
Two transcription factors Runx2 and Osx have been shown to be required for 
osteoblast differentiation. Mice deficient for these factors develop a cartilaginous 
skeleton with complete absence of osteoblasts (Ducy, et al., 1997; Komori et al., 
1997; Otto et al., 1997; Nakashima, et al., 2002). To understand whether Tmem16f 
is acting upstream or downstream of the transcription factors Runx2 and Osx, in situ 
hybridization was performed on the limbs of Runx2 and Osx deficient mice. We 
detected no Tmem16f expression in these mutants (Fig. 13 D, H, I). This indicates 
that Tmem16f acts downstream of these transcription factors in osteoblasts.  
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Figure 13: Tmem16f acts downstream of Ihh, Runx2 and Osx. 
Ihh- and Tmem16f riboprobes were hybridized on the sections of E16.5 limbs of wild type (A, E), Ihh 
oversxpressing (B, F), Ihh-/- (C, G), Runx2-/- (D, H) and Osx-/- (I) mice. Ihh is expressed in 
prehypertrophic chondrocytes of wt (A), Col-II/Ihh (B), Runx2-/- (D) and Osx-/- (not shown) mice. No Ihh 
expression could be detected in Ihh-/- mice (C). Tmem16f is expressed in the newly formed bone and 
the periosteum, flanking the Ihh expression domain (E, pink arrows). Tmem16f expression is 
upregulated in osteoblasts of Ihh overexpressing mice adjascent to Ihh expression domain (F, arrow). 
No Tmem16f expression could be detected in Ihh-/- (G), Runx2-/- (H) and Osx-/- (I) mice.  
3.3 Localization of Tmem16f in the cell 
To define the localization of Tmem16f protein, COS-7 cells were transfected with 
Tmem16f-EGFP fusion constructs. The ORF of Tmem16f was cloned into the 
pEGFP-N3 vector in front of the EGFP gene. The stop-codon of Tmem16f was 
removed to enable the synthesis of the Tmem16f-EGFP-fusion protein (Fig. 14 A). 
Transient transfection of COS-7 or CHO cells with this construct showed, that 
Tmem16f is localized in the cytoplasm, but not in the nucleus (Fig. 14 C). Control 
transfection of the same cells with the vector, expressing only EGFP showed equal 
distribution of EGFP protein throughout the cell, including nucleus (Fig. 14 B). 
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Figure 14: Localization of Tmem16f. 
Tmem16f gene was cloned into pEGFP-N3 to generate a Tmem16f-EGFP fusion protein (A). COS-7 
cells were transiently transfected with EGFP control and Tmem16f-EGFP expression plasmids. EGFP 
is distributed throughout the whole cell including the nucleus (B), whereas Tmem16f is localized in the 
cytoplasm and absent from the nucleus (C).  
3.4 Inactivation of Tmem16f 
One of the common approaches for analysis of the gene function is inactivation of 
the gene in mouse. There are two major strategies used to inactivate a gene of 
interest: a targeted deletion of the gene and a gene trapping. To analyze the function 
of Tmem16f we decided first to create a Tmem16f deficient mouse.  
The necessary steps of gene targeting procedure are:  
• screening of PAC library  
• cloning of the targeting construct 
• electroporation of the targeting vector into appropriate ES cells 
• screening for the positive ES clones (for homologous recombination event) 
• blastocyst injection 
• transfer of injected blastocysts into the uterus of foster mice 
• breeding for germline transmission 
Results 
55 
 
We used an approach in which the targeting vector with a positive selection cassette 
replaces the gene of interest. Important elements of a replacement vector are the 
homology to the targeted locus, a positive selection marker, bacterial plasmid 
sequence and a linearization site outside of the homologous sequence of the vector 
(Hasty, et al., 2003). A common strategy of gene targeting is to replace the complete 
gene of interest. In mice most people delete single or several exons due to the size 
of the genes. The strategy in that case is to delete exons containing the start codon 
of the ORF or sequences encoding critical functional domains. Due to a large intron 
sequences between the exons of Tmem16f and presence of the alternatively spliced 
exons 2a and 2b we decided to delete the first exon of Tmem16f which contains the 
only identified translation initiation site thus preventing the synthesis of all possible 
isoforms of Tmem16f.  
An alternative approach to the targeted deletion of a gene is a gene-trap. This was 
established for large scale random mutagenesis in mice and the rapid identification 
of the mutated genes. The basic gene trap vector contains a splice-acceptor 
sequence upstream of the reporter gene ß-Geo, a fusion of ß-galactosidase and 
neomycin phosphotransferase II (Stryke et al., 2003). This vector inserts randomly 
into the genome. If inserted into the intron of a gene, the splice acceptor will be used 
by the splicing machinery. The fusion transcript will contain sequences from exons 
upstream to the insertion site joined to the ß-Geo marker. 
Here we used the gene trap approach in parallel to the straight deletion strategy. As 
ES cells carrying an integrated gene trap cassette are commercially available long 
and difficult procedures of cloning and screening of ES clones can be avoided. The 
gene trap also allows investigating the function of the truncated form of the gene 
product, thus possibly predicting functional domains of N-terminal end of a protein. It 
is easy to follow the gene expression pattern in mouse embryos performing X-gal 
staining. With the gene trap approach it is possible to compare the long version of 
Tmem16f to the shorter version, Ano6_202.  
3.4.1 Screening for PAC clones containing Tmem16f genomic region 
To create a targeting construct it is needed to clone the genomic sequences 
upstream and downstream of the targeted locus into the targeting vector. These 
sequences are called 5’- and 3’ arms, respectively. It was demonstrated that the 
frequency of homologous recombination is adversely affected by the presenceof 
vector-target mismatches (teRiele, et al., 1992; Wurst, Auerbach and Joiner, 1994). 
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To avoid such mismatches targeting vectors are generated using "isogenic" DNA to 
optimize the efficiency of gene targeting. ES cells used for electroporation were 
derived from 129/Sv mice. Therefore, the PAC library of the same mouse strain was 
chosen. P1-derived Artificial Chromosome (PAC) cloning systems are specifically 
designed for cloning of large genomic DNA fragments ranging in size from 60 kb to 
150 kb. PACs are plasmid-based and thus DNA is easily isolated and manipulated 
(Sambrook and Russell, 2001). Therefore, a genomic library was purchased to 
identify a PAC clone, which would contain a large fragment of at least first exon of 
Tmem16f and surrounding genomic sequences.  
A DNA probe of 714bp complementary to the start of the first intron of Tmem16f was 
prepared by PCR amplification (Fig. 15 A). This probe was hybridized on the filters of 
mouse genomic PAC library RPCI21 (Osoegawa et al., 2000). Seven filters PAC1 to 
PAC7 covered the whole library. Eight clones gave positive signal after hybridization 
(Fig. 15 B) and were subsequently analyzed for the presence of Tmem16f genomic 
region.  
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Figure 15: Hybridization of 714bp probe on the mouse genomic PAC library 
RPCI 21. 
Design of 714bp probe for Southern blot hybridization (A). The primer fw was designed to match the 
end of the 1stexon of Tmem16f and the primer rev located 714 bp downstream. (A) Positive clones 
were detected after Southern blot hybridization of 714bp probe on PAC filters (B, arrows) 
 
DNA was purified and digested with three different restriction enzymes producing 
DNA fragments of specific length. After hybridization with the 714bp probe only three 
PAC clones 379, 449 and 473 contained DNA fragments of the correct size: 4.2 kb 
fragment after the digestion with BglII, 3.5 kb fragment after the digestion with XbaI 
and 10 kb fragment after the digestion with HindIII restriction enzymes (Fig. 16 A). 
To confirm that these clones contain the entire 5’ genomic part of Tmem16f DNA, a 
PCR with the primer pairs for 5’- and 3’-arms was performed. It revealed that only 
clone 379 included both 5’- and 3’- sequences of genomic region of the 1stexon (Fig. 
16 B). The 5’-arm sequence was also present in clones 449 and 473, however, the 
3’-arm sequence was absent in these clones (Fig. 16 B). Other five clones detected 
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by PACs analysis seem to be false positive. Thus, clone 379 was the only one, 
which was suitable for further cloning of a targeting construct. 
 
 
Figure 16: Analysis of PAC clones. 
Southern blot hybridization of PAC clones DNA with 714bp probe. Correct size bands of ~4.2 kb 
appear after BglII digestion, ~3.5 kb after XbaI digestion and ~ 10kb fragment appear after digestion 
with HindIII restriction enzyme of PAC clones number 379, 473, 449 (A). Amplification of the 5’- and 
3’-armsequences of the first exon. Only clone 379 gave positive result for both 3’ and 5’ genomic 
regions (B). 
 
3.4.2 Cloning of the targeting construct 
It was shown that the ideal length of homologous sequences in the targeting vector 
is in the range of 5 to10 kb- the greater is the length of homology the higher is the 
targeting frequency (Thomas and Capecchi, 1987; Hasty, et al., 1991). Another 
necessary condition is that the targeting vector should include one short arm and 
one long arm of homologous sequences in purpose to screen ES cell for correct 
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integration site of the selection cassette. Considering these guidelines, we cloned 5’ 
arm sequence of 3,5 kb and 3’ arm sequence of 7,9 kb into the targeting vector 
pWH9 (Fig. 17) upstream and downstream of the positive selection cassette, 
respectively (Fig. 17 and Fig. 18 A). 
 
 
Figure 17: Scheme of the targeting vector pWH9. 
The cassette, including ß-Gal and Neo was inserted into pBSSK vector using EcoRI and SalI sites 
resulting in pWH9 vector. Only unique XhoI site is available for cloning of the 5’ arm and SalI and NotI 
sites for cloning of the 3’ arm (asterisks). pWH9 vector was kindly provided by R. Fässler. 
 
Since the 5’ arm was shorter than the 3’ arm, we first cloned it into pWH9. Primers 
containing XhoI sites on their ends were used to amplify the 3,5 kb of 5’ homologous 
sequence of the 1st exon from the PAC clone 379 DNA. The fragment was directly 
cloned into pWH9 previously linearized with XhoI restriction enzyme resulting in 
pWH9 -5’arm construct. Since the 3’ arm was 7,9 kb long we first cloned it in to pBSII 
SK vector. Two fragments of 3’arm were amplified using primers containing SalI and 
BamHI sites (4,3 kb fragment) and BamHI and XbaI sites (3,6 kb fragment). SalI- 
BamHI fragment of the 3’arm was first cloned into pBS II SK and then BamHI- XbaI 
fragment was ligated to the resultant construct thus assembling the complete 3’- arm 
sequence. The complete 3’ arm fragment was subcloned into pWH9 using the SalI 
and NotI sites present in pBS II SK vector (Fig. 18 A). 
The targeting construct was linearized and electroporated into R1 ES cells (derived 
from 129/Sv mice). The cells were grown for several days under selection condition 
(G418). Picked clones were analyzed for the proper recombination event (Fig. 18 B). 
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Figure 18: Cloning strategy for the targeted deletion of Tmem16f gene. 
The first exon of Tmem16f gene was replaced with positive selection cassette, which included ß-
Galactosidase and neomycin resistance genes (A). The integration of the cassette led to the insertion 
of the additional sites for HindIII and EcoRV enzymes which served for ES cell clone analysisby 
Southern blot (B). 9,7kb and 25kb fragments indicate the wild type allele after digestion of genomic 
DNA with HindIII and EcoRV respectively. 5,4kb and 14,4 kb fragments detect the knockout allele 
after digestion of genomic DNA with HindIII and EcoRV respectively (B).  
3.4.3 Screening for homologous targeting events by Southern blot 
To confirm the correct integration of the knockout cassette, the ES cell clones were 
analyzed by Southern blot using 5’ and 3’ probes (Fig. 18 B). The integration of the 
neo cassette led to the insertion of additional HindIII and EcoRV restriction sites 
which were used for the analysis of the ES cell clones for the integration site by 
Southern blot (Fig. 18 B). The external probes for the hybridization were chosen so 
that they would hybridize close to the site of integration, but outside of the 
homologous regions to detect the integration site at the correct genomic locus. In 
case of correct site of cassette integration, the fragments of 5.4 kb and 14.4 kb 
should be produced after digestion of genomic ES cell DNA with HindIII or EcoRV, 
respectively (Fig. 18 A, B, HindIII and EcoRV fragments). 
In a first step 360 ES clones were analyzed for the 5’ side using HindIII enzyme for 
genomic DNA digestion (Fig. 18 B). Second, positive clones number 77, 103, 104, 
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122, 127, 153, 180, 220, 222, 269 and 283 were selected for the analysis for the 3’ 
side of integration. Their genomic DNA was digested with EcoRV. All of them 
demonstrated the correct integration site (Fig. 18 B). Finally, two ES cell clones 
number 77 and 127 were chosen for further blastocyst injection, which was done by 
the group of R. Fässler. The injected blastocysts from black C57Bl/6J mice are 
transferred into the uterus of foster mice, where they develop into chimeric mice. 
Germ-line transmission was recognized by mating these chimeric mice to C57Bl/6J 
mice. ES-cell-derived germ cells result in agouti animal, since agouti is dominant 
over black. 
 
3.4.4 Gene trap allele of Tmem16f 
By searching the gene trap databases we have found ES cells, containing gene trap 
cassette inserted into intron 13 of Tmem16f available. These cells were 
subsequently ordered from Bay Genomics company. The position of the integration 
site of the cassette was first provided by Bay Genomics database. We confirmed this 
data by PCR using forward primer complimentary to the 3’-end of exon13 and the 
reverse primers complimentary to the integration cassette (Fig. 19 A, B). Sequencing 
of the PCR-products identified the integration of the gene trap cassette into intron 13, 
approximately 300 bp downstream of exon 13 (Fig. 19 B). The same pair of primers 
was used for the genotyping of the gene trap mice (chapter 2.2.14). Considering the 
shorter isoform, Ano6-202, the gene trap cassette is inserted into the second intron 
(Fig. 19 C). Therefore, the truncated form of both isoforms of Tmem16f protein would 
be produced. Since the conserved DUF590 domain starts in exon 16 of Tmem16f, 
both truncated isoforms of Tmem16f would lack the DUF 590 domain (Fig. 19 A, C).  
To create a Tmem16f gene trap mice, ES cells carrying the gene trap cassette in the 
13th intron of Tmem16f were injected into C57Bl/6J mouse blastocysts, which in turn 
were transferred into the uterus of foster mice where they develop into chimeric mice 
(performed in the laboratory of R. Fässler). Chimeric mice were crossed with 
C57Bl/6J to follow the germ-line transmission. ES-cell-derived germ cells result in 
agouti animals. 
3.4.5 X-gal staining of the Tmem16f gene trap embryos 
Due to the presence of ß-galactosidase in the gene trap cassette it is possible to 
follow the expression of the Tmem16f gene in vivo with X-gal staining. 
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Figure 19: Gene trap integration site. 
The gene trap cassette was inserted into intron 13 of Tmem16f (A).Forwardprimer to the 3’- end of the 
exon 13 of Tmem16f and two reverse primers to the gene trap cassette were used to define a gene 
trap integration site (A, arrows). PCR fragments of these primer pairs (B). The gene trap cassette was 
inserted into intron 2 of the shorter isoform Ano6-202 (C).DUF590- domain of unknown function starts 
in the exon 16 of Tmem16f, SA- splice acceptor, ß-Gal is ß-galactosidase gene, neo- neomycin 
resistance. M- DNA molecular weight marker 
 
To investigate the expression of Tmem16f in vivo, E14.5 embryos of Tmem16fgt/gt 
mice were stained with X-gal to detect ß-Gal activity. Cells which normally express 
Tmem16f gene would express ß-galactosidase gene instead. Staining with X-gal (a 
substrate for ß-Gal) reveals those cells in which the Tmem16f is normally expressed. 
The pattern of ß-Gal expression was identical in heterozygous and homozygous 
Tmem16f mutants. This pattern reproduced the results of expression of the 
endogenous Tmem16f gene detected by in situ hybridization in the ossification 
centers of ulna and radius, in the ossified parts of ribs and in the skull bones where 
the ossification process has also taken place (Fig. 20 A, arrows).Closer look at the 
ulna and radius of E 14.5 mouse embryos reveals that Tmem16f is expressed in the 
osteoblasts of periosteum (Fig. 20 B, C, arrows). 
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Figure 20: X-gal Staining of E 14.5 Tmem16fgt/gt embryo. 
The whole embryos were stained for ß-Galactosidase. Tmem16f is expressed in osteoblasts of the 
bone formed by endochondral (limbs, ribs) and intramembranous (bones of the skull) ossification (A, 
yellow arrows). Osteoblasts in the periosteum express ß-Gal (B, red arrow, magnification 5X). 
Expression of ß-Gal in the osteoblasts, higher magnification (C, red arrow, magnification 10X). 
 
3.5 Analysis of the phenotype of Tmem16f deficient and Tmem16f 
gene trap mice  
Since Tmem16f is expressed in osteoblasts, one would expect disturbed bone 
formation in Tmem16f deficient and Tmem16fgt/gt mice. On the other hand, different 
targeting strategies were used to create both mouse lines, one deleting entire gene, 
and splice for the other- deleting only 3’-end of the gene. Therefore, the first goal 
was to reveal and compare the phenotypes of Tmem16f deficient and Tmem16f 
gene trap mice. 
3.5.1 Skeletal phenotype of Tmem16f gene trap mice 
Skeletal preparation and staining for bone and cartilage indicated that Tmem16fgt/gt 
mice have delayed endochondral and intramembranous ossification. Long bones are 
curved and generally shorter in Tmem16fgt/gt mice (Fig. 21). The heterozygous mice 
were phenotypically normal (data not shown). In E15.5 wild type and heterozygous 
mice the ossification has already started in endochohndral and intramembranous 
bones (Fig. 21, A). In contrast, E 15.5 Tmem16f gt/gt mice had no or rarely few 
ossification centers (Fig. 21, C, arrows). The long bones of E 16.5 Tmem16fgt/gt mice 
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are ossified, but bent (Fig. 21, G, H, arrows). The bones of the skull are also ossified 
in mutant mice at E16.5. 
 
Figure 21: Skeletal phenotype of Tmem16f gene trap mice. 
Skeletons of E15.5 (A, B, C, D) and E16.5 (E, F, G, H) mice were stained with Alcian Blue and 
Alizarin Red for cartilage and bone, respectively. The skeletons of Tmem16fgt/gt embryos (C, G) are 
shorter than skeletons of heterozygous (A) and wild type (E) embryos. The long bones of mutant mice 
(C, H, yellow arrows) are shorter compared to heterozygous (A) and wild type mice (F). They are also 
bent and less ossified (C, H, yellow arrows). The rib cage is generally smaller in mutant mice (D, G) 
compared to wild type (B, E). The ribs of E 15.5 Tmem16fgt/gt mice are not ossified (D, arrow), while 
ossification takes place in heterozygous mice (B). The ribs of E 16.5 Tmem16f gt/gt mice are ossified, 
but curved (G, arrow). Intramembranous ossification is severely delayed in E 15.5 Tmem16f gt/gt 
mice (C, red arrow). 
 
Analysis of later stages, E18.5 and P0, showed dynamic changes in the ossification 
of Tmem16fgt/gt mice. First, most of the bones are ossified similar to those of the wild 
type. Second, the long bones are not that dramatically curved as they were at the 
early stages. The skull bones of Tmem16fgt/gt mice are strongly ossified as well, but 
the sutures are wider than the sutures of wild type mice (Fig. 22).  
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Figure 22: Alcian Blue and Alizarin Red staining of Po wild type (A, B, C) and 
Tmem16fgt/gt (D, E, F) skeletons. 
The long bones of mutant mice are well ossified and slightly curved (D, E, arrows) compared to the 
long bones of wild type mice (A, B). The skull bones of mutant mice are ossified similarly to those 
bones of the wild type, but the sutures are wider (F, arrow). 
3.5.2 Skeletal phenotype of Tmem16f deficient mice 
Analysis of the skeletons of Tmem16f null mice revealed the same phenotype as of 
Tmem16fgt/gt mice: ossification was delayed in mutant mice compared to 
heterozygous and wild type mice. 
At the embryonic stage E14.5 no bones are ossified in the mutant embryos while 
both, intramembranous and endochondral ossification have already taken place in 
wild type embryos as well as in heterozygous mice(Fig. 23). Mutant embryos are 
smaller in size and the cartilage anlagen of long bones, such as ribs and limbs, 
resemble the shape of bones of wild type mice (Fig. 23). Heterozygous mice are 
phenotypically normal. 
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Figure 23: Alcian Blue and Alizarin Red staining of E14.5 Tmem16f 
heterozygous and deficient skeletons. 
In E 14.5 wild type and heterozygous mice (A) the ossification has already taken place (bone is 
stained red). The embryos of Tmem16f deficient mice are smaller in size (B). No ossified bones can 
be seen in Tmem16f-/- embryos (B).  
 
At E15.5 the skeletons of Tmem16f null mice remain to be smaller compared to wild 
type mice (Fig. 24). At this stage there is no or rarely very little ossification in 
Tmem16f mutant mice. The cartilage anlagen of long bones are shorter and the 
limbs and ribs are bent (Fig. 24).  
At E 16.5 the bones of Tmem16f deficient mice become ossified. However, they are 
smaller in size than those of wild lype. The bones of Tmem16f-/- limbs and ribs are 
curved (Fig. 24). Heterozygous mice are phenotypically normal (data not shown). 
 
 
Figure 24: Skeletal phenotype of E 15.5 and E16.5 Tmem16f null mice. 
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Skeletons of E15.5 (A, B, C, D) and E 16.5 (E, F, G, H) mice were stained with Alcian Blue and 
Alizarin Red for cartilage and bone, respectively. The skeletons of Tmem16f-/- mice are significantly 
smaller than those of the wild type (C, G). There is no visible endochondral or intramembranous 
ossification taking place in E 15.5 mutant mice (C, D, arrows). The ribs are curved, but not ossified yet 
in mutant mice (D, arrow), compared to straight ossified ribs of wild type mice (B).The long bones of E 
16.5 Tmem16f-/- mice (G) are shorter compared to wild type or heterozygous mice (E). They are also 
bent and less ossified (G, H, arrows). The rib cage is generally smaller in mutant mice (H) compared 
to wild type or heterozygous mice (F). The ribs of E 16.5 Tmem16f null mice are ossified, but curved 
(H, arrow).  
 
Endochondral ossification in the forelimbs of Tmem16f deficient mice. 
Analysis of different stages of forelimb development revealed several differences 
between wild type and Tmem16f deficient mice. At all stages the mutant limbs are 
generally shorter than wild type limbs (Fig. 25 A). During embryonic development, 
the forelimbs of Tmem16f deficient mice have normal shape but are not ossified at 
E14.5, whereas the limbs of the wild type embryos have already started to ossify. At 
E15.5 the forelimbs of mutant mice are still not ossified, but already display a 
malformed shape (bending). At E16.5 the mutant limbs are ossified, but keep their 
malformed shape of E15.5 stage, whereas wild type limbs are straight (Fig. 25 A). At 
E18.5 and after birth (P0) the limbs remain slightly bent. Analysis of forelimbs of one 
month old mice revealed shortened bones and a smaller olecranon processes in 
limbs of mutant embryos compared to those of the wild type mice (Fig. 25 B, red 
arrows). Additionally, the ulna and radius are no longer bent, but twisted around 
each other, whereas ulna and radius of wild type mice are parallel to each other (Fig. 
25 B, black arrows). Analyzing early stages of limb development we found that the 
olecranon process of Tmem16f deficient mice was normal at E14.5. Starting from 
E15.5 the size of olecranon process of mutant mice was reduced but the elbow joints 
developed normally, suggesting a reduction of chondrocyte proliferation in olecranon 
process (Fig. 25 A, arrows). The cartilage anlagen of olecranon processes become 
ossified after birth and are completely ossified at the age of one month (Fig. 25 B, 
red arrows). 
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Figure 25: Endochondral ossification in the forelimbs of Tmem16f deficient 
mice. 
The limbs were stained with Alcian Blue and Alizarin Red for cartilage and bone, respectively. The 
limbs in the upper row are from wild type mice, the limbs in the lower row are from Tmem16f deficient 
mice. The forelimbs of Tmem16f mutant mice are generally smaller in size, they are not ossified at 
E14.5 and E15.5. The bones are bent at E15.5 and at the later stages compared to the wild type 
limbs of corresponding stages (A). The olecranon process of Tmem16f deficient mice is formed 
properly at E14.5 (pink arrows). It is reduced in size at later stages compared to the wild type limbs 
(A, red arrows). The long bones of the one month old mutants are shorter than those of the wild type 
mice. The ulna and the radius are twisted around each other in mutant mice, whereas these bones 
are parallel in the wild type mice (B, black arrows). The olecranon process is fully ossified in the limbs 
of Tmem16f deficient mice and is reduced in size compare to the wild type limbs. 
 
3.5.3 Comparison of endochondral ossification in Tmem16f deficient and 
Tmem16fgt/gt mice on molecular level 
To investigate, whether Tmem16f deficient and Tmem16fgt/gt mouse lines have the 
same phenotype we analyzed them in greater detail at the molecular level. Analyzing 
limbs at the stage of E15.5, we compared chondrocyte markers (Ihh, Col10a1) and, 
additionally, bone markers, such as MMP13 and Dkk. The zones of prehypertrophic 
and hypertrophic chondrocytes can be distinguished by expression of Ihh and 
Col10a1, respectively. MMP13 marks the terminal hypertrophic chondrocytes and 
bone. The region of expression of these markers was not altered in mutant mice 
compared to the wild type mice (Fig. 26). However, the expression of Dkk1, a marker 
for osteoblasts, was reduced in Tmem16f deficient and Tmem16fgt/gt mouse limbs, 
indicating that less bone is formed at that time point of development (Fig. 26). 
The comparison of endochondral ossification in Tmem16f deficient and Tmem16fgt/gt 
limbs on a molecular level confirmed the identical bone phenotype of both mouse 
lines. 
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Ihh, Col 10a1, MMP13 and DKK1 riboprobes were hybridized on the sections of E15.5 limbs of 
heterozygous mice (A, B, C, D, I, J, K, L), Tmem16f deficient (E, F, G, H) and Tmem16fgt/gt (M, N, O, 
P) mice. No significant differences were found between Ihh (A, E, I, M) and Col 10a1 (B, F, J, N) 
expression in mutant and heterozygous mice. MMP13 expression was also not altered in mutant mice 
(C, G, K, O) compared to the wild type mice. The region of Dkk1 expression (D, H, L, P) was reduced 
in both, Tmem16f deficient and Tmem16fgt/gt mutant mice. 
 
3.5.4 Mineralization and bone resorption in Tmem16f deficient and Tmem16fgt/gt 
mice  
The formation of bone is the result of the balance between the function of 
osteoblasts and osteoclasts. Osteoblasts form the bone, osteoclasts resorb it. 
Performing von Kossa and TRAP histological stainings we compared the 
mineralization and osteoclast number in Tmem16f deficient and Tmem16fgt/gt mice. 
In wild type mice the strongly mineralized periosteum and trabeculae were 
distinguishable at E16.5, whereas the periosteum and trabeculae of Tmem16f 
deficient and Tmem16fgt/gt mice were markedly less mineralized (Fig. 27, von Kossa 
staining). To determine whether this was caused by increased number of osteoclasts 
in the mutant limbs, we performed tartrate resistant acid phosphatase (TRAP) 
staining. TRAP is produced by the osteoclasts. We found no significant difference in 
number of osteoclasts between wild type and mutant mice (Fig. 27, TRAP staining). 
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Figure 26: Ossification in the forelimbs of E15.5 mice. 
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The sections of E16.5 limbs of wild type mice (A, B, C, G, H, I), Tmem16f deficient (D, E, F) and 
Tmem16fgt/gt (J, K, L) mice were stained with Hematoxylin and Eosin (HE) for the morphology (A, D, 
G, J), with von Kossa staining for calcium ions (B, E, H, K). TRAP staining (C, F, I, L) was performed 
to detect the oseoclasts. The size of trabeculae and the front of mineralization were markedly reduced 
in both mouse mutant lines (D, E, J, K) compared to the wild type mice (A, B, G, H), even though the 
number of osteoclasts was not altered.  
3.5.5 Delayed ossification in Tmem16f deficient mice 
To investigate the mechanism which regulates the ossification in the Tmem16f 
deficient mice, we analyzed more osteoblast markers to test whether the reduced 
mineralization is due to the smaller number or to the reduced activity of the 
osteoblasts. In situ hybridization of Osterix (Osx) and Bone sialoprotein (Bsp) 
riboprobes on E14.5 forelimbs showed no alteration in expression of these 
osteoblast markers between wild type and Tmem16f deficient mice (Fig. 28). At this 
stage both, Osx and Bsp, are expressed in the periosteum. In mutant mice the 
intensity of the expression of both osteoblast markers and the distance from 
periarticular region to the domain of their expression in periosteum were equal to 
those of the wild type mice. However, no mineralization was detected at this time 
point of development in the limbs of Tmem16f deficient mice (Fig. 28). 
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Figure 27: Histological analysis of E16.5. 
Results 
71 
 
The same chondrocyte and osteoblast markers were used to analyze limbs of E15.5 
Tmem16f deficient mice. As at the earlier stage, no differences were seen in 
chondrocyte proliferation or differentiation (Fig. 29, Ihh and Col 10a1 riboprobes). 
Expression of Osx and Bsp was also not altered in Tmem16f deficient mice, which 
suggests normal development of early osteoblasts. However, von Kossa staining 
showed weaker mineralization of the limbs of Tmem16f deficient mice, the 
trabeculae are less mineralized. On the Fig. 29 one can see that the front of 
mineralized periosteum in Tmem16f deficient limb (Fig. 29 J) does not expand as far 
up to Ihh expression domain as in wild type limb (Fig. 29 E). The same is true for the 
averages taken over ten wild type and ten Tmem16f deficient limbs, however this 
difference is not statistically significant in our experiments at the stage E 15.5. 
 
 
 
 
Ihh, Col 10a1, Osx and Bsp riboprobes were hybridized on the parallel sections of E14.5 limbs of 
heterozygous (A, B, C, D) and Tmem16f deficient (F, G, H, I) mice. The mineralization was detected 
by von Kossa staining of the parallel sections of heterozygous (E) and Tmem16f deficient (J) mice. 
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Figure 28: Ossification in E14.5 Tmem16f deficient mice. 
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Hypertrophic differentiation is not affected in Tmem16f deficient mice (Ihh and Col 10a1 probes). 
Expression of the osteoblast markers such as Osx and Bsp in the periosteum is not affected in the 
mutant mice, whereas no calcification of the periosteum was detected in the Tmem16f deficient mice 
(arrows). The magnification is 5X. 
 
 
 
 
Ihh, Col 10a1, Osx and Bsp riboprobes were hybridized on the parallel sections of E15.5 limbs of wild 
type (A, B, C, D) and Tmem16f deficient (F, G, H, I) mice. Von Kossa staining was performed on the 
parallel sections of wild type (E) and Tmem16f deficient (J) mice. Expression of markers for 
chondrocytes (Ihh, Col 10a1) and for osteoblasts (Osx, Bsp) showed no difference in the development 
of early osteoblasts between the wild type and Tmem16f deficient mice. The distance from the 
periarticular region to the border of Bsp expression in the periosteum is not altered (D, I, red arrows), 
whereas the distance from the periarticular region to the border of ossified periosteum is larger (green 
line shows the distance from periarticular region to the border of calcified periost, orange line shows 
the ossification border of mineralized periost, black line represents the border of mineralized periost in 
wild type limbs, transferred to the picture of Tmem16f deficient mice). The radius is shown at the 
magnification of 10X. 
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Figure 29: Ossification in E15.5 Tmem16f deficient mice. 
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Further we analyzed the limbs of E16.5 Tmem16f deficient mice. The bone is formed 
in the centre of the anlage in both Tmem16f deficient and wild type mice. The 
expression pattern of chondrocyte specific markers such as Ihh and Col 10a1 in the 
Tmem16f deficient mice were similar to those of the wild type mice (Fig. 30). This 
indicates that there is no alteration in the chondrocyte proliferation and differentiation 
in Tmem16f deficient mice. The early osteoblast markers Osx and Bsp are 
expressed clearly in the periosteum surrounding Ihh expression domain in 
prehypertrophyc chondrocytes and also in the trabeculae of wild type mice. 
However, their expression is much weaker in the trabeculae of Tmem16f deficient 
mice (Fig. 30). E16.5 is the earliest stage of embryonic development, when the 
expression of late osteoblast marker Osteocalcin (Osc) can be detected. In the wild 
type it is strongly expressed in the periosteum which borders trabecular bone and it 
is weaker in the trabeculae. However, Osc expression is markedly reduced in the 
limbs of Tmem16f deficient mice (Fig. 30). This evidence indicates delayed 
maturation of osteoblasts in Tmem16f deficient mice. Moreover, the trabeculae of 
Tmem16f deficient mice are much weaker, smaller and more dispersed than the 
trabeculae of wild type mice (Fig. 30).  
Molecular analysis of endochondral ossification in Tmem16f mutants revealed that 
proliferation and differentiation of chondrocytes is not affected, whereas the 
ossification process is severely delayed. Interestingly, the expression of early 
osteoblast markers like Osx and Bsp is unaffected in the periosteum, but reduced in 
the trabeculae. Later osteoblast differentiation is disturbed as shown by a delayed 
onset of mineralization and reduced Osteocalcin expression. 
To test whether the mineralization of the periosteum in Tmem16f deficient mice is 
significantly delayed compared to wild type mice, we performed several 
measurements. First, the distance from the periarticular region to the border of Bsp 
expression in the periosteum was measured in wild type and Tmem16f deficient 
mice (length “a”, onset of Bsp expression) (Fig. 31 A, C). 
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Ihh, Col 10a1, Osx, Bsp and Osc riboprobes were hybridized on the parallel sections of E16.5 limbs of 
Tmem16f heterozygous (A, B, C, D, E) and Tmem16f deficient (G, H, I, J, K) mice. Von Kossa 
staining was performed on the parallel sections of wild type (F) and Tmem16f deficient (L) mice. Ihh 
(A, G) and Col 10a1 (B, H) riboprobes mark prehypertrophic- and hupertrophic chondrocytes, 
respectively. Osx (C, I) and Bsp (D, J) are expressed by early osteoblasts. Their expression in 
trabecular bone is downregulated in Tmem16f deficient mice compare to the wild type mice (D, J, 
arrows). The expression of Osc, a marker of the late osteoblasts is markedly reduced in Tmem16f 
deficient mice, compare to wild type mice (E, K, arrows). The trabeculae of Tmem16f deficient mice 
are smaller in size and weaker mineralized than those of the wild type (F, L, arrows). The ulna and the 
radius are shown at the magnification of 5X. 
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Figure 30: Ossification in E16.5 Tmem16f deficient mice. 
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Second, the distance from periarticular region to the mineralized periosteum was 
measured in wild type and Tmem16f deficient mice (length “b”, mineralized 
periosteum) (Fig. 31 B, D). Subtracting the length “a” from the length “b”, we 
determined the distance from the border of Bsp expression in the periosteum to 
mineralized periosteum (length “c”). The distance between Bsp expression in the 
periosteum and mineralized periosteum (length “c”) was 71 % larger in Tmem16f 
deficient mice than in the wild type mice (length “c”, Fig. 31 B, D, E).  
These results indicate that despite normal chondrocyte proliferation and 
differentiation in Tmem16f deficient mice the osteoblast maturation is retarded at the 
later stages of osteoblast differentiation process. Therefore, mineralization of the 
bone is also delayed. 
 
Figure 31: Mineralization in E16.5 Tmem16f deficient mice. 
In Tmem16f mutants the onset of Bsp expression is unaffected (A, C, E), whereas the mineralized 
region of the periosteum is significantly shorter than in the wild type (B, D, E). n=10, unpaired student 
t test.  The radius is shown at the magnification of 10X. 
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As a first hypothesis of why there is a delay in the mineralization during the 
development of endochondral bones, we suggested that there is a reduction in the 
synthesis and/or the activity of alkaline phosphatase (TNAP or AP). However, no 
dramatic changes were found in the activity of alkaline phosphatase in the limbs of 
E16.5 Tmem16f deficient mice compare to wild type mice (Fig. 32), suggesting other 
mechanisms acting downstream of Tmem16f gene.  
 
 
 
 
Cryosections of E16.5 forelimbs of Tmem16f heterozygous mice (A, B, C, D) and Tmem16f deficient 
mice (E, F, G, H) were stained to detect alkaline phosphatase activity. No significant difference was 
found in alkaline phosphatase activity (A, E, C, G) between wild type and mutant mice. The parallel 
sections were stained for calcium ions (B, F, D, H). The magnification is 5X for (A, B, E, F) and 10X 
for (C, D, G, H). 
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Figure 32: Alkaline phosphatase activity in E16.5 Tmem16f deficient mice. 
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3.5.6 Intramembranous ossification in Tmem16f deficient mice 
As the first step to reveal the cause of the delayed ossification of skull bones, we 
analyzed the expression of early and later osteoblast markers such as Bsp and Osc. 
At stage E16.5 the expression of Bsp was upregulated, whereas the expression of 
Osc was downregulated in intramembranous bones of Tmem16f deficient mice (Fig. 
33). Parallel sections of E16.5 mouse heads were also stained for calcium ions. The 
mineralization of intramembranous bones was markedly reduced as it was shown by 
von Kossa staining (Fig. 33).  
Further we analyzed the width of the interfrontal suture. Sutures are the fibrous 
tissues uniting the bones of the skull. They are also the major sites of bone growth 
(Opperman, L. A., 2000). We measured the distances between Bsp and Osc 
expression zones in frontal bones and between the fronts of the mineralization of 
these bones (Fig. 33). The distance between two mineralized bones (the suture) was 
wider in Tmem16f deficient mice than in the wild type mice, but the distance between 
the zones of Osteocalcin expression in mutant mice was similar to those of the wild 
type (Fig. 33 C, F and B, E). Also it is interesting, that the distance between the Bsp 
expression domains of the frontal bones was smaller in Tmem16f deficient mice than 
in the wild type mice (Fig. 33, A, D). That suggests that there is some compensating 
mechanism for mineralization of intramembranous bones in Tmem16f deficient mice. 
Finding this mechanism demands the analysis of additional markers and later stages 
of mouse development.  
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Bsp and Osc riboprobes were hybridized on the sections of E16.5 heads of heterozygous mice (A, B) 
and Tmem16f deficient mice (D, E). Von Kossa staining was performed on the parallel sections of the 
same heads of the wild type (C) and Tmem16f deficient (F) mice. The expression of Bsp is 
upregulated, whereas expression of Osc is downregulated in intramembranous bones of Tmem16f 
deficient mice. The distances between Bsp expression domains of frontal bones in Tmem16f deficient 
mice is smaller than in the case of the wild type (A, D, arrows). The distances between Osc 
expression domains of the same bones in mutant mice is comparable to the wild type case (B, E, 
arrows). Mineralization in the intramembranous bones of Tmem16f deficient mice is delayed. The 
distance between the ossification fronts (width of the suture) of frontal bones is larger in Tmem16f 
deficient mice than in the wild type (C, F, arrows). The magnification is 2.5X. 
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Figure 33: Intramembranous ossification in E16.5 Tmem16f deficient mice. 
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4. Discussion 
4.1 Structure of Tmem16f  
The complete cDNA sequence was obtained by combining two approaches. First, 
the EST clones matching the originally identified 769 bp region of Tmem16f were 
sequenced. Second, a 5’RACE method was used to verify the complete 5’-end 
sequence of Tmem16f.  By now, we obtained the complete Tmem16f mRNA 
sequence by ESTs sequencing. The 5’end obtained using this method was longer 
than those resultant from 5’RACE. The 5’RACE experiment revealed an existence of 
the second alternatively spliced exon. Even more, there were two isoforms of the 
second exon found: 2a and 2b. Considering the number of clones obtained and 
sequenced during 5’RACE experiment (which is based on the extraction of the 
mRNA and synthesis of the cDNA) one can suggest that those two isoforms of the 
second exon are rarely expressed. Only single clones contained exons 2a or 2b, 
whereas the other exons, number 1, 3, 4, 5 were present in all clones. Our data 
indicate that Tmem16f consist of 21 exons, including the second alternatively spliced 
exon, whereas ensembl database has annotated a Tmem16f of 20 exons. The third 
exon resulting from our experiments represents the second exon of Tmem16f 
annotated by Ensembl database. It was found that Tmem16f covers 184 kb of the 
genomic region on mouse chromosome 15. The transcript of Tmem16f gene is 5680 
bp.  
Analysis of two other members of Tmem16 family by different research groups 
revealed several isoforms of Tmem16A and GDD1/TMEM16E (Caputo et al., 2008; 
Tsutsumi et al., 2005). For the GDD1/TMEM16E transcript 22 exons were identified 
forming the longest isoform. The other thirteen isoforms were comprised of different 
combinations of alternative exons 4, 6, 16b, 20 and 21 (Tsutsumi et al., 2005). These 
data indicate that there might be several other alternatively spliced exons detected 
for Tmem16f. Since the 5’RACE was performed using a gene specific primer to the 
5th exon of Tmem16f, the other possible isoforms could be detected by PCR using 
primers to different exons of Tmem16f starting from the 5th exon. RT-PCR using 
primers complementary to the parts of different exons of Tmem16f confirmed in silico 
predicted intron-exon structure of Tmem16f but did not identify any other isoforms for 
Tmem16f (see chapter 3.1.3 and Fig. 10A, C). The PCR products were produced 
using primers covering exon 3 to exon 8, exon 6 to exon 11a and exon 11b to exon 
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16, exon 17to exon 20.  We have determined Tmem16f ORF of 2736 nucleotides (in 
mouse) which was identical to those found later in the database (Ensembl). The 
open reading frame starts in the exon 1 and ends in the exon 21 of Tmem16f. It 
encodes a protein of 911 amino acids. 
A short isoform of Tmem16f (Ano6-202) was predicted by Ensemble. It represents 
the 3’-sequence of Tmem16f starting from exon 13 of Tmem16f. Ano6-202 has an 
alternative start site in a genomic sequence of intron 12. An ORF for the Ano6-202 
comprises 1455 nucleotides and encodes a polipeptide of 484 amino acid residues. 
First nine amino acids are encoded by the first exon of Ano6-202 and do not match 
the sequence of Tmem16F protein. 
Analysis of amino acid sequence revealed that Tmem16F protein contains eight 
potential transmembrane domains. The domains 6, 7 and 8 are a part of the DUF590 
domain. These domains are conserved among the members of TMEM16 family. For 
the plasma membrane both N- and C-terminal ends of the protein are exposed to the 
cytoplasm. There were six N-linked glycosylation sites predicted for Tmem16F at the 
amino acid residues 330, 362, 494, 778, 785 and 803 (data from UniProtKB/Swiss-
Prot). For the GDD1/TMEM16E protein there were five putative glycosilation sites 
found using MOTIF and PSORT II programms (Tsutsumi et al., 2004). This data 
suggests that Tmem16f and GDD1/TMEM16E represent glycoproteins.  
In present work the Tmem16F protein was analyzed only in silico. All data collected 
for Tmem16F protein was a prediction which might give a first clue about possible 
structure and function of Tmem16F protein.  These results need to be further proved 
experimentally.  
 
4.2 Tmem16f is expressed in osteoblasts 
As Tmem16f was initially found in a screen for Ihh-target genes, it was important to 
know whether Tmem16f is expressed in the same or adjacent tissue as Ihh, by 
chondrocytes or osteoblasts or by other cell types. With in situ hybridization 
experiments on E 14.5 and E 16.5 mouse embryos it was established that Tmem16f 
is expressed by osteoblasts of newly formed bone and periosteum. However, in the 
study of another research group a broader expression of Tmem16f was detected. At 
E14.5 Tmem16f expression was detected in the epithelium of lung, and weak 
expression was observed in the lung mesenchyme. Tmem16f expression was also 
detected in the epithelium of small intestine at this stage and weak expression was 
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observed in the mesenchyme of the small intestine and in the epithelial and 
mesenchymal components of trachea, ovary, kidney and stomach. At E16.5 
Tmem16f was found in the epithelium and mesenchyme of the esophagus (Rock and 
Harfe, 2008). We suggest that the differences in the detected patterns and sensitivity 
of detection may lie in the methods used by different groups.  
The other members of Tmem16 family were also found to be expressed in various 
different tissues. Tmem16A was shown to be expressed in the epithelium of the 
trachea and lungs, esophageal mesenchyme, epithelium of the posterior stomach, 
thymus and the aorta, in the perichondria of the developing vertebrae and ribs (Rock 
et al., 2008; Rock and Harfe, 2008). Mouse GDD1/TMEM16E was shown to be 
strongly expressed in the bone (Tsutsumi et al., 2004). At E14.5 GDD1/TMEM16E 
was expressed in the mesenchyme surrounding the digits and carpal/tarsal bones 
(Mizuta et al., 2007). Weak GDD1/TMEM16E protein expression was detected in the 
bones of E14.5 limbs. GDD1/TMEM16E protein was detected later in the 
prehypertrophic chondrocytes of E18.5 limbs and in the hypertrophyc chondrocytes 
of epiphyseal growth plate of adult mice. In adult mice GDD1/TMEM16E was 
expressed by the osteoblasts of endosteum and periosteum, as well as in the 
articular cartilage cells. This protein was also found in the myofibers of the adult 
mouse heart (Mizuta et al., 2007). 
Considering all data together, Tmem16f seems to be more bone-specific member of 
Tmem16 family than the others. Expression of Tmem16e by the chondrocytes and 
later in development by the osteoblasts gives an idea that both genes might function 
synergistically and that one gene can probably compensate for the absence of 
another. 
4.3 Localization of Tmem16f in the cell 
To get the first clue of where the protein of interest is localized in the cell we 
performed the fast method where the Tmem16f-EGFP fused construct was easily 
transfected into COS-7 or CHO cells. We have identified TMEM16F as localized in 
the cytoplasm and not in the nucleus. Which compartment of the cell Tmem16f 
resides is still remains unclear. This result is preliminary and need to be tested in 
other experimentst.  
Similar results were initially shown for GDD1/TMEM16E which is homologous to the 
Tmem16f. COS-7 cells were transfected with an expression vector containing human 
GDD1/TMEM16E cDNA tagged with V5 epitope at it’s 3’-end. From this experiment it 
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was established that GDD1/TMEM16E is localized in endoplasmatic reticulum 
(Tsutsumi et al., 2004). However, in later study the same research group used 
GDD1-specific antibodies and revealed that GDD1/TMEM16E protein is residing 
mainly within intracellular membrane vesicles, and also in plasma membrane (Mizuta 
et al., 2007). 
Another supportive data was established for Tmem16A protein. It was detected in 
plasma membrane (shown by transient and stable transfection of HEK-293 and FRT 
cells. Tmem16A protein had a FLAG epitope) (Caputo et al., 2008). 
Taken all together these data seem to suggest that members of Tmem16 protein 
family are localized in plasma membrane and within intracellular membrane vesicles. 
To detect precise Tmem16f localization in the cell other experiments using specific 
antibody should be performed.  
4.4 Targeting of Tmem16f gene: deletion and gene trap strategies  
There are different strategies used by investigators to study the function of the gene. 
In our approach we have used two strategies to unravel the function of Tmem16f.  
First, the targeted deletion was performed to eliminate the 1st exon of Tmem16f. Due 
to the large introns between the exons it was technically not possible to delete the 
whole gene. Therefore, only the first exon containing the start codon of Tmem16f 
was deleted thus preventing the synthesis of the long isoform of Tmem16f. However, 
this strategy does not eliminate the synthesis of the potential shorter isoform of 
Tmem16f (Ano6-202)  
Second, ES cells carrying gene trap cassette inserted into intron 13 of Tmem16f 
gene were generated by Bay Genomics. That allowed to analyze mice in which the 
synthesis of both isoforms of Tmem16f would be disrupted. Therefore, the conserved 
DUF590 domain could be analyzed. Additionally, the presence of the ß-
galactosidase gene in the gene trap cassette allow to follow the expression pattern 
of Tmem16f in mouse embryos by performing X-gal staining.  
Taken together the results of two strategies allow for the comparison of two isoforms 
of the protein and possibly for the analysis of DUF590 domain and potential domains 
located on the N-terminus of Tmem16f.  
4.5 Functional analysis of Tmem16f gene 
First analysis of Tmem16f deficient and Tmem16f gene trap mouse lines during 
embryogenesis revealed identical phenotype discovered for both mouse lines. 
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Mutant mice had delayed start of ossification, shortening and bending of the long 
bones and delay in ossification of skull bones. The heterozygous mice of both mouse 
lines were phenotypically normal. In present study we have analyzed the bone 
phenotype of Tmem16f deficient mice on molecular level more in detail. 
 
4.5.1 Impaired ossification in Tmem16f deficient mice.  
The analysis of the phenotype of Tmem16f was performed in two steps. First, 
skeletal preparations were performed of mouse embryos of different stages, of 
newborn and 1 month old mice. Second, analysis on the molecular level was 
performed, using in situ hybridization and histological techniques.  
The earliest time point for skeletal analysis was E14.5. At this stage we established 
that no ossification could be detected in the mutant embryos while both, 
intramembranous and endochondral ossifications have already taken place in wild 
type embryos. All limbs and ribs of mutant mice have normal shape. Mutant embryos 
are generally smaller in size than wild type embryos. At stage E15.5 there was still 
no (or rarely very little) ossification seen in Tmem16f mutant mice. The skeletons of 
Tmem16f mutant mice were smaller and the long bones are shorter compared to the 
wild type embryos. The limbs and ribs were bended in Tmem16f deficient mice. At 
E16.5 the bones of Tmem16f mutant mice started to ossify but the long bones (i.e. 
ribs and limbs) were still shorter and kept the curved shape seen at the stage E15.5. 
All bones of Tmem16f deficient mice were less ossified than the bones of wild type 
mice. At later stages, such as E18.5 and P0, most of the bones were ossified similar 
to those of the wild type. The long bones were not that dramatically curved as they 
were at the early stages. The skull bones of Tmem16f mutant mice were strongly 
ossified as well, but the sutures were wider than the sutures of wild type mice.  
Analysis of one month old mice revealed slightly shortened bones and smaller 
olecranon processes of mutant limbs compared to those of the wild type mice. The 
ulna and radius were no longer bent, but twisted around each other in Tmem16f 
deficient mice, whereas ulna and radius of wild type mice are parallel to each other. 
The ribs of mutant mice were also not bent any more.  
The finding of the shorter olecranon process in one month mutant mice led to 
additional analysis of olecranon process at early stages. We found that at E14.5 the 
olecranon process of Tmem16f deficient mice was the same shape and size as the 
olecranon process of wild type mice. Starting from E15.5 the size of olecranon 
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process of mutant mice was reduced but the elbow joints developed normally, 
suggesting a reduction of chondrocyte proliferation in olecranon process. The 
cartilage anlage of olecranon process become ossified later after birth and is 
completely ossified at the age of one month in wild type as well as in mutant mice. 
However, it remains to be much smaller than in wild type mice 
Despite the severe embryonic skeletal phenotype Tmem16f deficient mice survive 
after birth and are fertile. These data indicates possible rescue by some other gene 
acting later or simultaneously with Tmem16f during the development. 
We suggest that one hypothetical candidate for this role might be Tmem16E 
because it belongs to the same protein family and because of its expression pattern. 
It was shown that GDD1/TMEM16E protein is weakly expressed in the bones of 
E14.5 mouse limbs. Later this protein was detected in the prehypertrophic 
chondrocytes of E18.5 limbs and in the hypertrophyc chondrocytes of epiphyseal 
growth plate of adult mice. In adult mice GDD1/TMEM16E was expressed by the 
osteoblasts of endosteum and periosteum, as well as in the articular cartilage cells 
(Mizuta et al., 2007). To prove this idea Tmem16E/ Tmem16f double knockout 
mouse needs to be generated and analyzed. 
4.5.2 Bone resorption and alkaline phosphatase activity are not affected in 
Tmem16f deficient mice 
The comparison of mineralization in Tmem16f deficient and wild type mice revealed 
that the periosteum and trabeculae of Tmem16f deficient mice were markedly less 
mineralized compare to the wild type during embryogenesis. The formation of bone 
is the result of the balance between the function of osteoblasts and osteoclasts. 
These data led to a suggestion that reduced mineralization in mutant mice could be 
caused by increased number of osteoclasts. Staining for TRAP which is produced by 
osteoclasts revealed no significant difference in number of osteoclasts between wild 
type and mutant mice. Therefore we suggest that bone resorption is not altered in 
Tmem16f deficient mice. 
As another hypothesis of why there is a delay in the mineralization during 
development of endochondral bones, we suggested that there is a reduction in the 
synthesis and/or the activity of alkaline phosphatase. However, no significant 
difference was found in alkaline phosphatase activity in the limbs of Tmem16f 
deficient and wild type mice. These facts led to suggestion that other steps of 
mineralization process are regulated by Tmem16f gene.  
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4.5.3 Delayed ossification in Tmem16f deficient mice 
In attempt to identify the mechanism which regulates the ossification in the Tmem16f 
deficient mice, we analyzed forelimbs and skull of Tmem16f mice on molecular level. 
To investigate whether the reduced mineralization is due to the delay in hypertrophic 
chondrocyte differentiation or due to smaller number or the reduced activity of the 
osteoblasts we hybridized cartilage and bone markers on the forelimbs of Tmem16f 
deficient and wild type mice. An expression of Ihh (marker of prehypertrophic 
chondrocytes), Coll10 (hypertrophic chondrocytes) and MMP13 (marker of terminal 
hypertrophic chondrocytes) was not altered at any stage of embryonic development 
in Tmem16f deficient mice compared to wild type mice. There were also no changes 
found in expression of Runx2 (data not shown), which is normally expressed by 
prechypertrophic and chypertrophic chondrocytes and osteoblast progenitors and 
differentiated osteoblasts (Inada, et al., 1999; Kim, et al., 1999; Takeda, et al., 2001; 
Stricker, et al., 2002). This indicated that proliferation and differentiation of 
chondrocytes were not affected in Tmem16f mutants. 
Analyzing the expression of the osteoblast markers such as Osterix (Osx), Bone 
sialoprotein (Bsp) and Osteocalcin (Osc) and comparing it to the mineralization of 
the limb (detected by von Kossa staining) we revealed that later osteoblast 
differentiation is disturbed in Tmem16f deficient mice. The expression of early 
osteoblast markers like Osx and Bsp was not altered in the limbs of E14.5 and E15.5 
mutant mice, which indicates normal development of early osteoblasts. However, the 
limbs were less mineralized. At E16.5 the expression of Osx and Bsp was unaffected 
in the periosteum, but reduced in the trabeculae of Tmem16f deficient mice. The 
expression of osteocalcin was markedly reduced at this stage of development 
indicating that later osteoblast differentiation is disturbed in Tmem16f deficient mice. 
This is supported by the fact that onset of mineralization was delayed in mutant mice 
(it might be, that it is probably the cause of the delayed mineralization in mutant 
mice). The trabeculae of Tmem16f deficient mice are smaller and more dispersed 
than the trabeculae of wild type mice (shown by Von Kossa staining). The 
mineralization of the periosteum in Tmem16f deficient mice is significantly delayed 
compared to wild type mice while the Bsp or Osx expression is not altered in the 
periosteum.  
Since the skull bones are formed by intramembranous ossification we analyzed the 
expression of early and later osteoblast markers such as Bsp and Osc in the skull 
bones and compared that with the front of ossification of these bones at stage E16.5 
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(the earliest stage when the skull bones of mutant mice get ossified). The expression 
of Bsp was upregulated and the distance between the Bsp expression domains of 
the frontal bones was smaller in Tmem16f deficient mice than in the wild type mice. 
The expression of Osc was downregulated but the distance between the zones of 
Osteocalcin expression in mutant mice was not changed compared to the wild type. 
The mineralization of intramembranous bones was markedly reduced and the 
distance between two mineralized bones (the suture) was wider in Tmem16f 
deficient mice than in the wild type mice. An unexpected upregulation and broader 
expression of Bsp together with downregulation and equal distribution of Osc 
suggest possible existence of some compensating mechanism for mineralization of 
intramembranous bones in Tmem16f deficient mice.  
4.5.4 Tmem16f is important for proper mineralization of embryonic bones 
Analyzing Tmem16f deficient mice we revealed that both, intramembranous and 
endochondral ossification are delayed in absence of Tmem16f. The ossification 
takes place but to a lesser extend in mutant mice than in wild type mice during 
embryogenesis. We suggest that Tmem16f is important for the proper mineralization 
of the embryonic bones but less important in adult life. The mechanism by which 
Tmem16f may promote the mineralization process during embryogenesis remains 
unknown. Since Tmem16E and Tmem16f constitute a subfamily among other 
Tmem16 proteins (Katoh, 2004 (a)) we propose that Tmem16E may act 
synergistically but later in time, overlapping with Tmem16f in the process of mineral 
deposition. These proteins were predicted to have similar structure where DUF590 
domain is on C-terminal end. GDD1/TMEM16E was also shown to be strongly 
expressed in the bone (Tsutsumi et al., 2004). An additional analysis of Tmem16E 
deficient mice is necessary to unravel the function of Tmem16E. 
Tmem16E/Tmem16f double knock-out mice also need to be generated and analyzed 
for the possible synergistical role of these proteins in the process of bone 
mineralization.  
Recent findings have revealed that Tmem16A, a member of Tmem16 protein family 
represents a novel calcium-dependent chloride channel (CaCC) (Caputo et al., 2008; 
Schroeder et al., 2008; Yang et al., 2008). Tmem16A is expressed differently than 
Tmem16F and plays role in proper tracheal cartilage formation (Rock et al., 2008). 
However, due to common predicted protein structure and similarity to other Tmem16 
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protein family members one can expect that Tmem16F and Tmem16E may also 
represent ion channels and play pivotal role in mineralization of the bone. 
4.5.5 Tmem16f acts downstream of Ihh, Runx2 and Osx 
Since Tmem16f was identified in a screen for Ihh-target genes we suggested that 
Tmem16f is most likely regulated by Ihh. It was previously shown, that Tmem16f 
expression is elevated by 7% in the E 14.5 mouse limbs treated with Shh in limb 
culture compared to non-treated limbs (activation of hedgehog signaling; Wenzel, 
2003). The finding that Tmem16f expression was absent in mice lacking Ihh, and 
expanded in the mice overexpressing Ihh led to a suggestion that Tmem16f is 
regulated by Ihh. It is still to be confirmed whether this regulation is direct or indirect. 
Since Tmem16f is expressed in osteoblast, it was important to analyze whether this 
gene acts downstream of essential transcription factors Runx2 and Osx. It has been 
previously shown that there are no osteoblasts formed in mice deficient for Runx2 or 
Osx (Ducy, et al., 1997; Komori et al., 1997; Otto et al., 1997; Nakashima, et al., 
2002). It was also established that Osx is acting downstream of Runx2 (Nakashima, 
et al., 2002). We found that Tmem16f is not expressed in mice lacking Runx2 or 
Osx. However, both factors, Runx2 and Osx are expressed in Tmem16f null mice 
Therefore Tmem16f seem to act downstream of these transcription factors during 
osteoblast differentiation. 
Summarizing these data we suggest that Tmem16f is positively regulated by Ihh. 
However, it is not known yet whether this occurs directly or indirectly through 
transcription factors Runx2 and Osx (Fig. 34). Unknown factors may also form 
independent pathway of Runx2 and Osx.  
 
Figure 34: Positive regulation of Tmem16f by Ihh. 
Ihh activates Runx2, which further promotes Osx expression. Osx positively regulates Tmem16f which 
in turn promotes mineral deposition. Ihh may also act directly on Tmem16f or through other unknown 
factors. ß-Catenin promotes and maintains the expression of Osx and therefore is involved in the 
regulation of Tmem16f indirectly. 
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ATF4 is another transcription factor which is required for terminal differentiation of 
osteoblasts and controls the transcriptional activity of mature osteoblasts (Yang, et 
al., 2004; Franceschi, et al., 2007). ATF4 and Runx2 cooperatively regulate 
osteocalcin transcription (Xiao et al., 2005). Therefore, Tmem16 can be regulated by 
ATF. This might be established later. 
 
ß-Catenin, a central player in the canonical Wnt signaling might also potentially 
regulate Tmem16f. It was shown, that Wnt/ß-Catenin signaling promotes ossification 
acting downstream of Ihh (Day et al., 2005; Hill et al., 2005, Hu, 2005). Cells do not 
progress to osteoblasts expressing Osx if ß-Catenin is removed (Hill et al., 2005; Hu 
et al., 2005). It was established that ß-Catenin is also essential for maintenance of 
expression of Runx2 and Osx in osteoblasts (Rodda and McMahon, 2006). 
Therefore, we suggest that Tmem16f might be regulated by ß-Catenin (Fig. 34). That 
has to be investigated in the future.  
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5. Summary  
The majority of skeletal elements are formed through endochondral ossification in 
which the signal molecule Indian hedgehog (Ihh) plays a key role. It regulates 
chondrocyte proliferation and differentiation and promotes osteoblast differentiation 
thus coordinating chondrogenesis with osteogenesis. In a previous study our group 
identified several candidate genes, which potentially act downstream of Ihh. In this 
study one of these genes, the transmembrane protein 16f (Tmem16f) was 
investigated in more detail and the skeletal phenotype of Tmem16f deficient mice 
was characterized.  
First, the Tmem16f gene was analyzed in silico and mapped to the mouse 
chromosome 15 (15F1) covering 184 kb of the genomic region. Tmem16f consists of 
21 exons and encodes a protein of 911 amino acids. By performing 5´-RACE we 
have discovered that the second exon is alternatively spliced. Additionally a shorter 
isoform of Tmem16f named Ano6-202 was predicted by the Ensembl database. It 
represents the 3´-sequence of the long isoform (exons 13 to 21) and an alternatively 
spliced exon 12b on the 5’-end. Furthermore the in silico analysis predicted 8 
transmembrane domains and six N-linked glycosylation sites for Tmem16f.  
Second, we defined an expression pattern of Tmem16f specifically in the developing 
bone and periosteum. In E14.5 and E16.5 wild-type mouse embryos Tmem16f is 
expressed by the osteoblasts of the forming bone and periosteum surrounding the 
Ihh expression domain. However, in mouse mutants, deficient for important 
regulators of bone development, such as Ihh, Runx2 or Osterix, the expression of 
Tmem16f was not detected, indicating that Tmem16f acts downstream of Ihh and the 
transcription factors Runx2 and Osx. 
Third, the transient transfection of COS7-cells with Tmem16f-GFP fusion construct 
demonstrated that Tmem16f is localized in the cytoplasm. 
The main focus of this study was to decipher the function of Tmem16f. Therefore a 
mouse line carrying a targeted deletion of the first exon of Tmem16f was generated. 
Additionally, we created a second mouse line carrying a gene trap cassette inserted 
into intron 13 of Tmem16f, which leads to disruption of both isoforms of Tmem16f. 
Analysis of the skeletal preparations of Tmem16f mutant embryos revealed that both 
transgenic mouse lines display the same phenotype. The endochondral and 
intramembranous ossification was markedly delayed, the long bones of limbs and 
ribs were shortened and curved compared to those of wild type embryos. The 
sutures between the skull bones were wider in mutant embryos than those of wild 
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type embryos. At the age of 1 month the bones of Tmem16f mutant mice were 
slightly shorter and the olecranon processes of the ulna were smaller than those of 
the wild type mice. At this age, the long bones of the limbs and ribs were not bent 
any more as seen in the embryonic stage. However, the ulna and radius were 
twisted around each other in Tmem16f deficient mice.  
Analysis of endochondral ossification on the molecular level revealed that 
proliferation and differentiation of chondrocytes is not affected, whereas the 
ossification process is severely delayed. The expression of early osteoblast markers 
is unaffected in the periosteum, but reduced in the trabeculae. Later osteoblast 
differentiation is disturbed as shown by a delayed onset of mineralization and 
reduced Osteocalcin expression.  
These experiments indicate that Tmem16f is required for proper bone mineralization 
during embryogenesis but might have less important function in adult life. 
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6. Zusammenfassung 
Die meisten Skelettelemente werden durch endochondrale Ossifikation gebildet. Das 
Signalmolekül Ihh spielt in diesem Prozess eine wichtige Rolle. Ihh reguliert die 
Proliferation und Differenzierung der Chondrozyten und die Differenzierung der 
Osteoblasten. Ihh koordiniert auf diese Weise die Chondrogenese mit der 
Osteogenese. In früheren Untersuchungen unserer Gruppe wurden verschiedene 
Kandidatengene identifiziert, die möglicherweise downstream von Ihh funktionieren. 
In der vorliegenden  Arbeit wurde eines dieser Kandidatengene (Tmem16f) 
untersucht und der Skelettphänotyp der Tmem16f defizienten Mäusen 
charakterisiert.  
Zuerst, wurde das Tmem16f Gen in silico analysiert. Es liegt auf dem 
Mauschromosom 15 in der Bande 15F1. Der Genlokus erstreckt sich über 185 kb 
und umfasst 21 Exons. Tmem16f kodiert für ein Protein mit 911 AS. Durch 5‘-RACE 
wurde festgestellt, dass das zweite Exon alternativ gespliced wird. Des Weiteren 
wird von der von Ensembl Datenbank  eine kurze Isoform vorausgesagt, die als 
Ano6-202 bezeichnet wird. Diese  entspricht  dem 3‘-Sequenzbereich der langen 
Isoform (Exon 13 bis 21) mit einem alternative gesplictem Exon 12b am  5‘-Ende. 
Weitere in silico Analysen sagen für das Tmem16f Protein acht 
Transmembrandomänen und sechs N-verknüpfte Glycosilierungsstellen voraus.  
Zweitens, wurde eine spezifische Genexpression von Tmem16f  im sich entwickelten 
Knochen und im Periost nachgewiesen. In E 14,5 und E 16,5 Wildtyp 
Mäuseembryonen wird Tmem16f von Osteoblasten im sich entwickelnden Knochen 
und Periost neben der Ihh-Expressionsdomäne exprimiert. Da in Ihh-, Runx2- bzw. 
Osx- defizienten Mutanten keine Tmem16f Expression detektierbar ist, scheint 
Tmem16f downstream von Ihh, Runx2 und Osx zu agieren.  
Drittens, durch transfektion von einem Tmem16f-GFP Fusionskonstrukt in COS-7 
Zellen konnte eine zytoplasmatische Lokalisation von Tmem16f nachgewiesen 
werden.  
Der Schwerpunkt dieser Arbeit lag auf der funktionellen Untersuchung von 
Tmem16f. Hierzu wurden Mausmutanten, die eine Deletion des ersten Exons des 
Tmem16f-Gens tragen generiert. Außerdem wurde eine zweite Mauslinie kreiert, die 
eine Genetrapkassette im 13. Intron enthält, wodurch es zur Unterbrechung beider 
Tmem16f Isoformen kommt. 
Bei  der Analyse von Skelettpräparationen der Tmem16f Mutantenembryonen wurde 
festgestellt, dass beide Mauslinien den gleichen Phänotyp, einer stark verzögerten 
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Endochondralen und Desmalen Ossifikation zeigen Die Langknochen der 
Gliedmaßen und die Rippen der Tmem16f-Mausmutanten sind gebogen und 
verkürzt im Vergleich zu Wildtypmäusen. Die Schädelnähte sind bei den Mutanten 
breiter  als bei den Wildtypembryonen. Bei 1 Monat alten  Mausmutanten sind die 
Knochen etwas kürzer als bei Wildtypmäusen. Die Langknochen der Gliedmassen 
und die Rippen sind nicht mehr gebogen. Jedoch sind Ulna und Radius bei den 
Mausmutanten umeinander gedreht, während diese bei Wildtypenmäusen sind 
parallel verlaufen. 
Die Analyse der endochondrale Ossifikation auf molekularer Ebene zeigte, dass die 
Proliferation sowie die Differenzierung der Chondrozyten bei den Tmem16f-
Mausmutanten unverändert, jedoch die Ossifikation stark verzögert ist. Die 
Expression der frühen Osteoblastmarkern ist im Periost unverändert, aber in den 
Knochenbälkchen reduziert. Durch den Nachweis einer verzögerten Mineralisierung 
und reduzierten Osteocalcin Expressions konnte gezeigt werden, dass die 
Differenzierung der späten Osteoblasten verlangsamt ist. 
Diese Untersuchungen zeigen, dass Tmem16f für die korrekte 
Knochenmineralisierung während der embryonal Entwicklung notwendig ist, jedoch 
bei adulten Tieren eine untergeordnete Rolle spielt. 
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8. Appendix  
8.1 Abbreviations 
 
aa amino acids 
AMP adenosine monophosphate 
AP alkaline phosphatase 
AS aminosäuren 
ATF adenosine triphosphate 
ATF4 activating transcription factor 4 
ß-Gal ß-galactosidase 
ß-Geo a fusion of ß-galactosidase and neomycin phosphotransferase II 
Bsp bone sialoprotein  
CaCC calcium-dependent chloride channel  
CIP - calf intestinal phosphatase 
Col-II/Ihh embryo mouse embryo misexpressing chicken Ihh under control of ColII 
promoter 
Col X (Col10a1) collagen type X 
DNA deoxyribonucleic acid 
DAPI- 4’,6-Diamino-2’-phenylindole 
DEPC diethylpyrocarbonate  
DKK1 Dickkopf 1 
DNA Desoxyribonucleic acid 
DUF590 domain of unknown function 590 
E embryonic stage 
ECM extracellular matrix 
ES embryonic stem 
EST(s) - expressed sequence tags 
FBS fetal bovine serum 
GDD gnathodiaphyseal dysplasia 
GFP green fluorescent protein 
GSP – gene specific primer 
gt gene trap 
h hour(s) 
HE Hematoxylin and Eosin (staining) 
Appendix 
107 
 
het heterozygous 
Ihh Indian hedgehog 
kb kilo base pairs 
ko knockout  
lacZ beta galactosidase gene 
min minute(s) 
ml milliliters 
µl microliters 
MMP matrix metalloproteases 
MVs matrix vesicles  
neor neomycine phosphotransferase-encoding gene 
NGSP nested gene specific primer 
NPP1 nucleotide triphosphate pyrophosphatase phosphodiesterase  
On osteonectin  
ORF open reading frame 
Osc osteocalcin  
Osp osteopontin 
Osx osterix 
PAC- P1-derived Artificial Chromosome 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
Pi inorganic phosphate  
PPi pyrophosphate  
PPR PTH/PTHrP receptor 
PS phosphatidylserine  
PTH parathyroid hormone 
PTHrP Parathyroid related peptide (Parathyroid hormone-related protein) 
5’RACE rapid amplification of cDNA  ends 
RNA ribonucleic acid 
RNAse ribonuclease 
RT reverse transcriptase 
RT-PCR reverse transcription PCR 
SA splice acceptor 
Shh Sonic hedgehog 
sec seconds 
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TAP tobacco acid pyrophosphatase  
TM transmembrane domain  
TMEM16A transmembrane protein A 
TMEM16E transmembrane protein E 
TMEM16F transmembrane protein F 
TNAP tissue nonspecific alkaline phosphatase  
TRAP Tartrate Resistant Alkaline Phosphatase 
wt wild type 
X-gal bromo-chloro-indolyl-galactopyranoside 
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